arginine has been researched along with neuropeptide y in 296 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 84 (28.38) | 18.2507 |
| 2000's | 130 (43.92) | 29.6817 |
| 2010's | 74 (25.00) | 24.3611 |
| 2020's | 8 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandes, F; Salaices, M; Tabernero, A; Vila, E | 1 |
| Flood, JF; Morley, JE | 1 |
| Beck-Sickinger, AG; Jung, G; Metzger, J; Schnorrenberg, G | 1 |
| Ishizaka, H; Matsunaga, T; Okumura, K; Tsunoda, R; Yasue, H | 1 |
| Brunner, HR; Grouzmann, E; Nussberger, J; Osterheld, MC; Schaad, NC; Waeber, B; Zanchi, A | 1 |
| Doods, HN; Eberlein, W; Engel, W; Entzeroth, M; Rudolf, K; Wieland, HA; Wienen, W | 1 |
| Doods, HN; Eberlein, W; Engel, W; Entzeroth, M; Rudolf, K; Wieland, HA; Wienen, W; Willim, KD | 1 |
| Lundberg, JM; Modin, A; Rudehill, A; Weitzberg, E | 1 |
| Chujo, M; Mori, H; Nakazawa, H; Okino, H; Tanaka, E | 1 |
| Cash, JM; Chrousos, GP; Crofford, LJ; Gold, PW; Kalogeras, KT; Kling, MA; Michelson, D; Pillemer, SR; Sternberg, EM; Wilder, RL | 1 |
| Morris, JL | 1 |
| Green, PG; Heller, P; Levine, JD; Luo, J | 1 |
| Modin, A; Pernow, J | 1 |
| Bennett, T; Gardiner, SM; Kemp, PA; Rubin, PC | 1 |
| Lundberg, JM; Rudehill, A; Weitzberg, E | 1 |
| Catipovic, B; Gether, U; Johansen, TE; Okamoto, H; Schwartz, TW; Wulff, BS | 1 |
| Fukuuchi, Y; Kobari, M; Matsuoka, S; Takeda, H; Tanahashi, N; Tomita, M; Yamawaki, T | 1 |
| Bonavera, JJ; Kalra, PS; Kalra, SP | 1 |
| Lundberg, JM; Modin, A | 1 |
| Burgess, GM; Harvey, JS | 1 |
| Beck-Sickinger, AG; Eberlein, W; Engel, W; Herzog, H; Martinez, R; Munoz, M; Rudolf, K; Sautel, M; Walker, P; Wittneben, H | 1 |
| Dumont, Y; Quirion, R; St-Pierre, JA | 1 |
| Grouzmann, E; Jeanrenaud, B; Rohner-Jeanrenaud, F; Sainsbury, A | 1 |
| Lundberg, JM; Malmstrom, RE | 2 |
| Cox, HM; Holliday, ND | 1 |
| Ekelund, M; Grundemar, L | 1 |
| Cantera, L; Edvinsson, L; Nilsson, T | 1 |
| Cantera, L; Edvinsson, L; Erlinge, D; Nilsson, T | 1 |
| Bucher, B; Doods, HN; Gicquiaux, H; Tschöpl, M | 1 |
| Bergdahl, A; Cantera, L; Edvinsson, L; Erlinge, D; Hedner, T; Nilsson, L; Nilsson, T; Sun, XY; Valdemarson, S | 1 |
| Ekelund, U; Erlinge, D | 1 |
| Edvinsson, L; Hedner, T; Sun, XY; Zhao, XH | 1 |
| Adham, N; Boyle, N; Branchek, TA; Cui, W; Dhanoa, DS; Dowling, B; Du, P; Gluchowski, C; Hou, C; Islam, I; Rueger, H; Salon, JA; Schmidlin, T; Shifman, Y; Tamm, JA; Vaysse, PJ; Walker, MW; Weinshank, RL; Yamaguchi, Y | 1 |
| Kennedy, B; Shen, GH; Ziegler, MG | 1 |
| Avramidis, P; Bischoff, A; Erdbrügger, W; Michel, MC; Münter, K | 1 |
| Grundemar, L; Ny, L | 1 |
| Chujo, M; Ito, K; Mohammed, MU; Mori, H; Nakazawa, H; Sekka, T; Shinozaki, Y; Tanaka, E; Tobita, K; Yamakawa, A | 1 |
| Balmér, KC; Lundberg, JM; Malmström, RE | 1 |
| Dumont, Y; Fournier, A; Pheng, LH; Quirion, R; Regoli, D | 1 |
| Donoso, MV; Huidobro-Toro, JP; Steiner, M | 1 |
| De Backer, JP; Van Liefde, I; Vanderheyden, PM; Vauquelin, G | 1 |
| Brown, N; Carrasco, C; Cortes, V; Donoso, MV; Fournier, A; Huidobro-Toro, JP | 1 |
| Fournier, A; Iyengar, S; Pheng, LH; Quirion, R; Regoli, D | 1 |
| Bischoff, A; Freund, A; Michel, MC | 1 |
| Grundemar, L | 2 |
| Chen, X; Cox, BF; Han, S; Naes, L; Westfall, T; Yang, CL | 1 |
| Buckingham, R; Widdowson, PS; Williams, G | 1 |
| Barrios, VE; Nelson, AG; Toombs, CF | 1 |
| Gribkoff, VK; Pieschl, RL; van den Pol, AN; Wisialowski, TA; Yocca, FD | 1 |
| Adner, M; Duckles, SP; Edvinsson, L; Krause, DN | 1 |
| Ech-Chadli, H; Lafond, J; Robidoux, J; Simoneau, L; St-Pierre, S | 1 |
| Bischoff, A; Michel, MC | 1 |
| De Backer, JP; Fraeyman, N; Van Liefde, I; Vanderheyden, PM; Vauquelin, G | 1 |
| Harro, J; Kask, A; Rägo, L | 1 |
| Andersson, A; Carlsson, PO; Jansson, L | 1 |
| Capurro, D; Donoso, V; Huidobro-Toro, JP; Mezzano, V | 1 |
| Burhop, KE; Drapeau, G; Moisan, S; Rioux, F | 1 |
| Aiglstorfer, I; Bernhardt, G; Buschauer, A; Dove, S; Gessele, K; Malawska, B; Merz, S; Moser, C; Schuster, A; Uffrecht, A | 1 |
| Beck-Sickinger, AG; Eriksson, H; Grundemar, L; Holmberg, SK; Larhammar, D; Sharma, P | 1 |
| García-Sacristán, A; Prieto, D; Simonsen, U | 1 |
| DeBacker, JP; Ebinger, G; Van Liefde, I; Vanderheyden, PM; Vauquelin, G | 1 |
| Dayao, EK; Hauser, GJ; Qureshi, NU; Shirali, S; Zukowska-Grojec, Z | 1 |
| Beauverger, P; Bourrienne, A; Boutin, JA; Canet, E; Dromaint, S; Duhault, J; Fauchère, JL; Félétou, M; Galizzi, JP; Germain, M; Henlin, JM; Imbert, J; Macia, C; Nicolas, JP; Rodriguez, M | 1 |
| Arch, JR; Buckingham, RE; Haynes, AC; McClue, S; Wilson, S | 1 |
| Abusnana, S; Bloom, S; Ghatei, M; Goldstone, AP; Gunn, I; Heath, M; Meeran, K; Morgan, DG; O'Shea, D; Rossi, M; Small, CJ; Smith, DM; Turton, M | 1 |
| Gehlert, DR; Sajdyk, TJ; Vandergriff, MG | 1 |
| Howard, M; Huidobro-Toro, JP; Irarrázabal, MJ; Morán, S; Racchi, H; Zalaquett, R | 1 |
| Kakizaki, Y; Kohsaka, A; Suda, T; Watanobe, H | 1 |
| Iyengar, S; Li, DL; Simmons, RM | 1 |
| Brown, N; Cortés, V; Donoso, MV; Fanjul, R; Fournier, A; Huidobro-Toro, JP; López, C | 1 |
| Oberhauser, V; Rump, LC; Vonend, O | 2 |
| Beauverger, P; Boutin, JA; Duhault, J; Félétou, M; Galizzi, JP; Nicolas, JP; Rodriguez, M | 1 |
| Bijak, M | 1 |
| Doods, HN; King, PJ; Widdowson, PS; Williams, G | 1 |
| Costa, A; Forsling, ML; Grossman, AB; Korbonits, M; Little, JA; Navarra, P; Trainer, PJ; Tringali, G | 1 |
| Capurro, D; Huidobro-Toro, JP | 1 |
| Koyama, T; Nakagawa, S; Nishi, N; Odagaki, Y | 1 |
| Dollinger, H; Doods, H; Eberlein, W; Engel, W; Esser, F; Gaida, W; Rudolf, K; Schnorrenberg, G; Wieland, HA | 1 |
| Carroll, M; Hinson, JP; Kapas, S; Renshaw, D; Thomson, LM | 1 |
| Bergdahl, A; Edvinsson, L; Hedner, T; Sun, XY; Zhao, XH | 1 |
| Potter, EK; Smith-White, MA | 1 |
| Andrianjara, CR; Calvet, A; Dahl, SG; Pascal, Y; Sylte, I | 1 |
| Beck-Sickinger, AG; Colmers, WF; Ho, MW | 1 |
| Goto, K; Kunii, K; Matsuzaki, I; Miwa, Y; Nambu, T; Sakai, A; Sakurai, T; Tsujino, N; Yamanaka, A | 1 |
| Brunkvall, J; Edvinsson, L; Lind, H; Nilsson, T | 1 |
| Conti, M; Rizzi, M; Samanin, R; Vezzani, A | 1 |
| Chouffani, S; El-Bizri, N; Hassan, G; Jacques, D; Sader, S; Shbaklo, H | 1 |
| Doods, H; King, PJ; Widdowson, PS; Williams, G | 1 |
| Bolwig, TG; Greisen, MH; Madsen, TM; Mikkelsen, JD; Nielsen, SM | 1 |
| Hoyo, Y; McGrath, JC; Vila, E | 1 |
| Aiglstorfer, I; Bernhardt, G; Buschauer, A; Dove, S; Hendrich, I; Moser, C | 1 |
| Lafond, J; Masse, A; Robidoux, J; Simoneau, L; St-Pierre, S | 1 |
| Chiba, S; Yang, XP | 4 |
| Lin, X; Narnaware, YK; Peter, RE; Peyon, PP | 1 |
| Diéguez, G; Fernández, N; García-Villalón, AL; Gómez, B; Martínez, MA; Monge, L; Padilla, J | 1 |
| Bobalova, J; Mutafova-Yambolieva, VN; Smyth, L; Ward, SM | 1 |
| Doods, HN; Weiser, T; Wieland, HA | 1 |
| Beierwaltes, WH; Carretero, OA; Dovgan, PS; Nypaver, TJ; Shin, LH | 1 |
| Gaillard, RC; Giacomini, M; Grouzmann, E; Pralong, FP; Voirol, M | 1 |
| Bryan, RM; Edvinsson, L; You, J | 1 |
| Cox, HM; Holliday, ND; Tough, IR; Zandvliet, DW | 1 |
| Bratt, AM; Hodge, CW; Kelley, SP; Nannini, MA | 1 |
| Eipper, BA; Hansel, DE; Ronnett, GV | 1 |
| Asakawa, A; Cheng, JT; Dobashi, R; Fujimiya, M; Inui, A; Kaga, T; Kasuga, M; Liu, IM; Morimoto, Y; Nishimura, N; Okita, M; Ueno, N | 1 |
| Feng, GG; Hamdy, O; Ishikawa, N; Maekawa, H; Shimada, Y | 1 |
| Ishiguchi, T; Kumagai, AK; Nakajima, M; Sone, H; Tada, H; Takahashi, T | 1 |
| Abbott, CR; Bloom, SR; Dakin, CL; Ghatei, MA; Morgan, DG; Russell, SH; Small, CJ | 1 |
| Malmström, RE | 2 |
| Peter, RE; Volkoff, H | 1 |
| De Backer, JP; Ebinger, G; Vanderheyden, PM; Vauquelin, G | 1 |
| Beauvillain, JC; Chuoï, MM; Croix, D; Jirou-Najou, JL; Knauf, C; Mortreux, G | 1 |
| Bucher, B; Dieterlen, A; Gaire, M; Galzi, JL; Gicquiaux, H; Lecat, S; Mély, Y; Takeda, K | 1 |
| Baudoin, FM; Lawrence, CB; Luckman, SM; Snape, AC | 1 |
| Chaffer, CL; Morris, MJ | 1 |
| Herzog, H; Potter, EK; Smith-White, MA | 2 |
| Lundberg, JN; Malmström, RE; Weitzberg, E | 1 |
| Dumont, Y; Fournier, A; Quirion, R; Redrobe, JP | 1 |
| Lundberg, JO; Malmström, RE; Weitzberg, E | 1 |
| Chen, SH; Cheung, RT; Fung, PC | 1 |
| Larhammar, D; Lecklin, A; Lundell, I; Männistö, PT; Paananen, L; Wikberg, JE | 1 |
| Taiwo, OB; Taylor, BK | 1 |
| Berglund, MM; Fredriksson, R; Larhammar, D; Salaneck, E | 1 |
| Parker, E; Stamford, A; Van Heek, M | 1 |
| Bell, D; McDermott, BJ; Nicholl, SM; Spiers, Jp | 1 |
| Heilig, M; Thorsell, A | 1 |
| Beck-Sickinger, AG; Cao, JQ; Colmers, WF; El Bahh, B | 1 |
| Banchelli, G; Matucci, R; Pirisino, R; Raimondi, L; Stillitano, F | 1 |
| Beck-Sickinger, A; Demuth, H; Dimitrijević, M; Kovacević-Jovanović, V; Stanojević, S; von Hörsten, S; Vujić, V | 1 |
| Audinot, V; Beauverger, P; Boutin, JA; Dromaint, S; Galizzi, JP; Imbert, J; Lamamy, V; Macia, C; Nicolas, JP; Rique, H; Rodriguez, M | 1 |
| Carvajal, C; Dumont, Y; Gardell, L; Lai, J; Ossipov, MH; Porreca, F; Quirion, R; Zhang, ET | 1 |
| Bolwig, TG; Gruber, SH; Husum, H; Mathé, AA | 1 |
| Chen, SH; Cheung, RT | 2 |
| Carvalho, AP; Carvalho, CM; Malva, JO; Silva, AP | 1 |
| Hexum, TD; Zheng, J; Zhou, G | 1 |
| Ekström, J; Sayardoust, S | 1 |
| Browning, KN; Travagli, RA | 1 |
| Bell, D; Bradley, E; Johnson, CD; Law, A | 1 |
| Cox, HM; Herzog, H; Hyland, NP; Sjöberg, F; Tough, IR | 1 |
| Beck-Sickinger, A; Dumont, Y; Fournier, A; Quirion, R; Thakur, M | 1 |
| Brain, SD; Chu, DQ; Costa, SK; Cox, HM; Herzog, H | 1 |
| Beck-Sickinger, A; Bedoui, S; Kawamura, N; Lin, Y; Miyake, S; Miyamoto, K; Oki, S; von Hörsten, S; Yamamura, T | 1 |
| Feng, GG; Hotta, Y; Ishikawa, A; Ishikawa, N; Kurimoto, N; Nan, YS; Nishiwaki, K; Shigei, T; Shimada, Y | 1 |
| Clarke, IJ; Estrada, KM; Morris, MJ; Pompolo, S; Tilbrook, AJ | 1 |
| Ishii, S; Kamegai, J; Oikawa, S; Shimizu, T; Sugihara, H; Tamura, H | 1 |
| Cho, YR; Kim, CW | 1 |
| Higuchi, H; Honglan, P; Tsurumaki, T | 1 |
| Flores, CM; Gibbs, J; Hargreaves, KM | 1 |
| Klein, T; Oberhauser, V; Rump, LC; Schwertfeger, E; Stegbauer, J; Vonend, O | 1 |
| Bennett, LA; Johnson, JM; Kosiba, WA; Saad, AR; Stephens, DP | 1 |
| Beck-Sickinger, AG; Meyer, M; Ove Ogren, S; Spiess, J; Stiedl, O; Tovote, P; von Hörsten, S | 1 |
| Jackson, DN; Milne, KJ; Noble, EG; Shoemaker, JK | 2 |
| Grider, JR; Mahavadi, S; Misra, S; Murthy, KS | 1 |
| Heilig, M; Rimondini, R; Thorsell, A | 1 |
| Beck, B; Stricker-Krongrad, A | 1 |
| Jiao, Y; Nadler, JV; Timofeeva, O; Tu, B | 1 |
| Cusick, MC; Primeaux, SD; Wilson, MA; Wilson, SP; York, DA | 1 |
| Habbel, S; Okonek, A; Quack, I; Rump, LC; Stegbauer, J; Vonend, O | 1 |
| Dautzenberg, FM; Neysari, S | 1 |
| Arnold, R; Mronga, S; Ortmann, E; Schäfer, MK; Tebbe, CG; Tebbe, JJ | 1 |
| Björkman, JA; Ilebekk, A; Nordlander, M | 1 |
| Balosso, S; Beck-Sickinger, AG; Colmers, WF; El Bahh, B; Gehlert, DR; Hamilton, T; Herzog, H; Sperk, G; Vezzani, A | 1 |
| Herzog, H; Holzer, P; Painsipp, E; Sperk, G; Thoeringer, CK; Wultsch, T | 1 |
| Acuna-Goycolea, C; van den Pol, AN | 1 |
| Ishii, S; Kamegai, J | 1 |
| Flores, CM; Gibbs, JL; Hargreaves, KM | 1 |
| Buus, CL; Frøbert, O; Gradin, KA; Li, JY; Simonsen, U | 1 |
| Ijames, SG; Lysle, DT; Saurer, TB | 1 |
| Brill, J; Fernald, RD; Huguenard, JR; Lee, M; Zhao, S | 1 |
| Deshmukh, M; Lal, B; Mazumdar, M; Sakharkar, AJ; Singru, PS; Subhedar, N | 1 |
| Kaiya, H; Kangawa, K; Maruyama, K; Matsuda, K; Miura, T; Shimakura, S; Shioda, S; Uchiyama, M | 1 |
| Herzog, H; Jiao, Y; Nadler, JV; Tu, B | 1 |
| Beck-Sickinger, AG; Bernhardt, G; Brennauer, A; Buschauer, A; Cabrele, C; Schneider, E; Ziemek, R | 1 |
| Domin, H; Smiałowska, M; Wierońska, JM; Zieba, B | 1 |
| Beck-Sickinger, AG; Lindner, D; Merten, N; Mörl, K; Rabe, N; Römpler, H; Schöneberg, T | 1 |
| Ishida, H; Iwata, M; Katayama, S; Kawahara, R; Nakagome, K; Shirayama, Y; Yamamoto, A | 1 |
| Adewale, AS; Macarthur, H; Westfall, TC | 1 |
| Asakawa, A; Fujimiya, M; Herzog, H; Inui, A; Kasuga, M; Meguid, MM; Miyazaki, J; Ninomiya, M; Ueno, N; Yuzuriha, H | 1 |
| Brownfield, MS; DeJoseph, MR; Dimitrov, EL; Urban, JH | 1 |
| Aguilar, E; Castellano, JM; Fernández-Fernández, R; Pinilla, L; Roa, J; Tena-Sempere, M | 1 |
| Berglund, MM; Gehlert, DR; Morin, M; Schober, DA | 1 |
| Macarthur, H; Westfall, TC; Wilken, GH | 1 |
| Danson, EJ; Heaton, DA; Herring, N; Lokale, MN; Paterson, DJ | 1 |
| Balducci, C; Carli, M; During, MJ; Kanter-Schlifke, I; Kokaia, M; Noe, F; Sørensen, AT; Vezzani, A | 1 |
| Beck-Sickinger, AG; Günther, R; Hofmann, HJ; Lindner, D; Merten, N; Mörl, K; van Dieck, J | 1 |
| Boissoneault, J; Bruijnzeel, AW; Isaac, S; Prado, M; Rylkova, D; Shah, HP | 1 |
| Hodges, GJ; Johnson, JM; Kosiba, WA; Zhao, K | 1 |
| During, MJ; Kanter-Schlifke, I; Kokaia, M; Lin, EJ; Sørensen, AT | 1 |
| Cox, HM | 1 |
| Kuphal, KE; Pedrazzini, T; Solway, B; Taylor, BK | 1 |
| Byku, M; Macarthur, H; Westfall, TC | 1 |
| Bernhardt, G; Buschauer, A; Keller, M; König, B; Weiss, S | 1 |
| Davis, M; Gutman, AR; Ressler, KJ; Yang, Y | 1 |
| Connelly, JJ; Crosslin, DR; Crossman, DC; Freedman, NJ; Ginsburg, GS; Goldschmidt-Clermont, PJ; Granger, CB; Gregory, SG; Hauser, ER; Haynes, C; Johnson, J; Jones, CJ; Kraus, WE; Muehlbauer, M; Nelson, S; Newgard, CB; Shah, SH; Sketch, MH; Stone, DH; Vance, J; Wang, L; Zhang, L | 1 |
| Adame, A; Crews, L; Gage, FH; Hersh, LB; Mante, M; Marr, RA; Masliah, E; Potkar, R; Rockenstein, E; Rose, JB; Spencer, B | 1 |
| Bartness, TJ; Dailey, MJ | 1 |
| Bhisikar, SM; Goyal, SN; Kokare, DM; Subhedar, NK; Upadhya, MA | 1 |
| Dandekar, MP; Kokare, DM; Nakhate, KT; Subhedar, NK | 1 |
| Akerberg, H; Chee, MJ; Colmers, WF; Cone, RD; Fan, W; Gruber, KA; Larhammar, D | 1 |
| Belsham, DD; Dhillon, SS; Gingerich, S | 1 |
| Miyazaki, R; Yamada, T; Yamamoto, T | 1 |
| Dandekar, MP; Kokare, DM; Singru, PS; Subhedar, NK; Upadhya, MA | 1 |
| Bürki, H; Chaperon, F; Fendt, M; Imobersteg, S; Lingenhöhl, K; McAllister, KH; Orain, D; Uzunov, DP | 1 |
| Bernhardt, G; Buschauer, A; Keller, M; Teng, S | 1 |
| Adams-Deutsch, T; Heilig, M; Nair, SG; Navarre, BM; Pickens, CL; Shaham, Y | 1 |
| Gourcerol, G; Larauche, M; Million, M; Taché, Y; Wang, L; Wu, SV; Yuan, PQ | 1 |
| Dandekar, MP; Deo, GS; Kokare, DM; Subhedar, NK; Upadhya, MA | 1 |
| Hegg, CC; Jia, C | 1 |
| Ellis, CG; Jackson, DN; Shoemaker, JK | 1 |
| Constantin, S; Klenke, U; Wray, S | 1 |
| Akerberg, H; Boukharta, L; Fällmar, H; Gutiérrez-de-Terán, H; Larhammar, D; Lundell, I; Mohell, N; Sjödin, P | 1 |
| Abe, K; Everhart, L; Jönsson-Rylander, AC; Kitlinska, J; Kuan-Celarier, A; Kuo, L; Li, L; Lu, C; Munivenkatappa, RB; Sun, CC; Sun, J; Tilan, J; Toretsky, JA; Zukowska, Z | 1 |
| Agasse, F; Cadet, JL; Coronas, V; Guégan, C; Jaber, M; Malva, JO; Nicoleau, C; Thiriet, N; Vallette, F | 1 |
| Kostić, S; Puljak, L; Sapunar, D; Vukojević, K | 1 |
| Bose, SC; Corder, G; Donahue, RR; Solway, B; Taylor, BK | 1 |
| Chopde, CT; Hirani, K; Kokare, DM; Kotagale, NR; Mali, PD; Nakhate, KT; Subhedar, NK; Taksande, BG; Ugale, RR | 1 |
| Chikahisa, S; Kitaoka, K; Nishino, S; Séi, H; Shimizu, N | 1 |
| Menard, JL; Trent, NL | 2 |
| Crespi, F | 1 |
| Gericke, MT; Klöting, N; Kosacka, J; Nowicki, M; Schröder, T; Spanel-Borowski, K | 1 |
| Bastianetto, S; Benoit, CE; Dumont, Y; Flores, G; Fournier, A; Morales-Medina, JC; Quirion, R | 1 |
| Chabeauti, PY; Chalon, S; Decressac, M; Frangeul, L; Gaillard, A; Herzog, H; Jaber, M; Pain, S; Thiriet, N; Vergote, J | 1 |
| Molina-Hernández, M; Téllez-Alcántara, NP | 1 |
| Cohen, H; Kaplan, Z; Kozlovsky, N; Liu, T; Mathé, AA; Zohar, J | 1 |
| Haas, P; Le, TP; Nave, H; Stadler, J | 1 |
| Cox, BR; Jijon, AM; Kash, TL; Li, C; Lowery-Gionta, EG; Navarro, M; Peňa, J; Pleil, KE; Rinker, JA; Sparrow, AM; Sprow, GM; Thiele, TE | 1 |
| Azuma, M; Kamijo, M; Kang, KS; Matsuda, K; Nishiguchi, R; Uchiyama, M; Yokobori, E | 1 |
| Kokare, DM; Nakhate, KT; Rangani, RJ; Subhedar, NK; Upadhya, MA | 1 |
| Cox, HM; Forbes, S; Herzog, H | 1 |
| Jackson, DN; Lacefield, JC; Medeiros, PJ; Shoemaker, JK; Twynstra, J | 1 |
| Gillespie, DG; Jackson, EK; Kochanek, SJ | 1 |
| Cavadas, C; Cortez, V; Estrada, M; Gonçalves, A; Marques, AP; Rosmaninho-Salgado, J; Santana, MM | 1 |
| Angulo, JA; Yarosh, HL | 1 |
| Hanawa, T; Hori, A; Ito, N; Nagai, T; Oikawa, T; Yabe, T; Yamada, H | 1 |
| Chen, PN; Hsieh, YS; Kuo, DY; Kuo, MH | 1 |
| Al-Khazraji, BK; Goldman, D; Jackson, DN; Medeiros, PJ; Novielli, NM | 1 |
| Abdel-Samad, D; Ahmarani, L; Avedanian, L; Bkaily, G; D'Orléans-Juste, P; Jacques, D; Magder, S; Perreault, C | 1 |
| Bernhardt, G; Buschauer, A; Keller, M; Lopuch, M; Memminger, M; Pop, N; von Angerer, E | 1 |
| Baumeister, P; Bernhardt, G; Buschauer, A; Keller, M; Pluym, N | 1 |
| De Lima, TC; dos Santos, VV; Farina, M; Lach, G; Prediger, RD; Rodrigues, AL; Santos, DB | 1 |
| Ai, J; Cai, BZ; Chen, QX; Liu, J; Sun, LH; Wang, N; Xie, F; Yang, BF; Ye, JH | 1 |
| Hara, T; Ide, S; Kaneda, K; Koseki, K; Maruyama, C; Minami, M; Naka, T; Ohno, A; Tamano, R; Yoshioka, M | 1 |
| Buttle, L; Espe, M; Jordal, AE; Lai, HV; Nguyen, MV; Rønnestad, I | 1 |
| Jiang, CL; Ni, HL; Wang, X; Wei, HF; Yang, F; Zhang, LD; Zhang, T; Zhou, JR | 1 |
| Azuma, M; Kikuyama, S; Matsuda, K; Morimoto, N; Shimizu, S | 1 |
| Aglawe, MM; Kotagale, NR; Paliwal, NP; Taksande, BG; Umekar, MJ | 1 |
| Ai, J; Niu, HF; Xie, F; Xu, L; Yan, Y; Yang, BF | 1 |
| Hodges, GJ; Sparks, PA | 1 |
| Chen, PN; Hsieh, YS; Kuo, DY; Liao, JM; Yu, CH | 1 |
| Bilbao, MG; Di Yorio, MP; Faletti, AG | 1 |
| Goebel-Stengel, M; Stengel, A; Taché, Y; Wang, L | 1 |
| Bharne, AP; Chopde, CT; Gawande, DY; Kokare, DM; Kotagale, NR; Taksande, BG | 1 |
| Cho, IJ; Kim, SC; Lee, BH; Wu, Y; Xu, Y; Yang, CH; Zhang, J; Zhao, R; Zhao, Z | 1 |
| Bálint, Z; Crnkovic, S; Egemnazarov, B; Gattinger, N; Ghanim, B; Jain, P; Klepetko, W; Kovacs, G; Kwapiszewska, G; Marsh, LM; Olschewski, A; Schermuly, RT; Seay, U; Weissmann, N | 1 |
| Borkar, CD; Desai, SJ; Kokare, DM; Nakhate, KT; Subhedar, NK | 1 |
| Cohen, H; Cohen, S; Kaplan, Z; Kozlovsky, N; Matar, MA; Mathé, AA; Vainer, E; Zohar, J | 1 |
| Ishii, T; Muroi, Y | 1 |
| Bernhardt, G; Buschauer, A; Dukorn, S; Hutzler, C; Keller, M; König, B; Kuhn, KK; Mollereau, C; Schindler, L; Weiss, S | 1 |
| Ahlbrand, R; Baccei, ML; Dolgas, CM; Rush, J; Sah, R; Schmeltzer, S; Schurdak, J; Vollmer, LL | 1 |
| Bernhardt, G; Biselli, S; Buschauer, A; Cabrele, C; Einsiedel, J; Gmeiner, P; Hübner, H; Keller, M; Kuhn, KK; Mollereau, C; Svobodová, J; Vanderheyden, PM; Wifling, D | 1 |
| Cabral, A; Perello, M; Portiansky, E; Sánchez-Jaramillo, E; Zigman, JM | 1 |
| Brooks, VL; Cassaglia, PA; Shi, Z | 1 |
| Bharne, AP; Kokare, DM; Nakhate, KT; Subhedar, NK; Yedke, SU | 1 |
| Anikina, TA; Krylova, AV; Masliuko, PM; Moiseev, KY; Zefirov, TL; Zverev, AA | 1 |
| Kornhuber, J; Zoicas, I | 3 |
| Cheng, G; Ding, X; Jia, T; Kou, X; Zhang, X; Zhang, Y | 1 |
| Clarke, IJ; Daniel, JA; Elsasser, TH; Foradori, CD; Jones, MA; Keisler, DH; Read, CC; Sartin, JL; Smith, JT; Steele, BP; Whitlock, BK; Zimmerman, AD | 1 |
| Babygirija, R; Cao, Y; Shi, B; Sun, W; Yang, Y; Zhang, F; Zheng, J; Zheng, X | 1 |
| Beck-Sickinger, AG; Bender, BJ; Bernhardt, G; Bosse, M; Burkert, K; Buschauer, A; Han, S; Huster, D; Kaiser, A; Keller, M; Kögler, LM; Larhammar, D; Li, B; Littmann, T; Meiler, J; Plank, N; Schmidt, P; Stevens, RC; Wifling, D; Wu, B; Xu, B; Yang, Z; Ye, S; Yi, C; Zhang, R; Zhao, Q | 1 |
| Appel, CK; Christiansen, SH; Diaz-delCastillo, M; Falk, S; Heegaard, AM; Woldbye, DPD | 1 |
| Dong, P; Gu, X; Li, M; Ma, B; Zhu, G; Zi, Y | 1 |
| Kingston, R; Lacey, T; Markham, CM; Smith, M; Sweeting, J | 1 |
| Brooks, VL; Cassaglia, PA; Pelletier, NE; Shi, Z | 1 |
| Dai, W; Liu, Y; Lv, X; Sun, C; Sun, Y; Zhang, Y | 1 |
| Carr, JA; Harris, BN; Islam, R; Prater, CM | 1 |
| Chen, W; Fu, W; Marvizon, JC; Taylor, BK | 1 |
| Chen, DY; Huang, TW; Li, ST; Young, TH | 1 |
| David, H; Hoang, JD; Salavatian, S; Swid, MA; Vaseghi, M; Yamaguchi, N | 1 |
| Atan, D; Barrington, AF; Butler, MJ; Coward, RJM; Graham, M; Heesom, KJ; Herbert, E; Hurcombe, JA; Ju, W; Kretzler, M; Lay, AC; Lewis, PA; McArdle, CA; Mountjoy, E; Nair, V; Neal, CR; Nelson, RG; Perrett, RM; Ramnath, RD; Satchell, SC; Welsh, GI; Wilson, MC | 1 |
| Ikeda, H; Kamata, T; Kamei, J; Ueda, D; Waddington, JL; Yonemochi, N | 1 |
| Galic, S; Loh, K; Oakhill, JS; Onda, DA; Scott, JW; Yang, CH | 1 |
| Clark, T; Conrad, M; Ertl, FJ; Gattor, AO; Gleixner, J; Gmeiner, P; Grätz, L; Horn, AHC; Keller, M; Konieczny, A; Neu, E; Schmidt, MF; Sticht, H; Wifling, D | 1 |
| Cimarosti, H; de Lima, TCM; Linartevichi, VF; Soares, ES; Vanz, F | 1 |
| Ann-Onda, D; Eizirik, DL; Fynch, S; Galic, S; Herzog, H; Laybutt, DR; Levinger, I; Lin, X; Liu, X; Loh, K; Loudovaris, T; Moreno-Asso, A; Nadarajah, S; Oakhill, JS; Pappas, EG; Scott, JW; Shi, Y; Smith, C; Thomas, HE; Yang, CH | 1 |
3 review(s) available for arginine and neuropeptide y
| Article | Year |
|---|---|
Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status.
Topics: Animals; Anti-Obesity Agents; Arginine; Body Weight; Energy Metabolism; Humans; Neuropeptide Y; Obesity; Pharmaceutical Preparations; Receptors, Neuropeptide Y; Structure-Activity Relationship | 2002 |
Brain neuropeptide Y (NPY) in stress and alcohol dependence.
Topics: Alcoholism; Animals; Anxiety; Arginine; Behavior, Animal; Benzazepines; Brain; Depression; Disease Models, Animal; DNA-Binding Proteins; Gene Expression; Genetic Heterogeneity; Humans; Neuropeptide Y; Receptors, Neuropeptide Y; Stress, Physiological | 2002 |
Regulation of Pancreatic β-Cell Function by the NPY System.
Topics: Animals; Arginine; Diabetes Mellitus; Humans; Insulin-Secreting Cells; Molecular Targeted Therapy; Neuropeptide Y; Receptors, Neuropeptide Y | 2021 |
1 trial(s) available for arginine and neuropeptide y
| Article | Year |
|---|---|
Role of central nervous system nitric oxide in the development of neurogenic pulmonary edema in rats.
Topics: Analysis of Variance; Animals; Arginine; Body Water; Enzyme-Linked Immunosorbent Assay; Medulla Oblongata; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Proteins; Pulmonary Edema; Rats; Rats, Wistar; Vagus Nerve | 2001 |
292 other study(ies) available for arginine and neuropeptide y
| Article | Year |
|---|---|
Effect of neuropeptide Y on adrenergic and non-adrenergic, non-cholinergic responses in the rat anococcygeus muscle.
Topics: Animals; Arginine; Autonomic Nervous System; Dose-Response Relationship, Drug; Electric Stimulation; Male; Muscle Contraction; Muscle Relaxation; Muscles; Neuropeptide Y; Nitroarginine; Norepinephrine; Prazosin; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System; Synaptic Transmission; Tyramine | 1992 |
Competitive antagonism of nitric oxide synthetase causes weight loss in mice.
Topics: Amino Acid Oxidoreductases; Analysis of Variance; Animals; Appetite Depressants; Appetite Regulation; Arginine; Dose-Response Relationship, Drug; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Weight Loss | 1992 |
Sulfonation of arginine residues as side reaction in Fmoc-peptide synthesis.
Topics: Amino Acid Sequence; Amino Acids; Arginine; Chromatography, High Pressure Liquid; Fluorenes; Molecular Sequence Data; Neuropeptide Y; Peptide Fragments; Spectrometry, Mass, Fast Atom Bombardment; Sulfones | 1991 |
Influence of inhibition of endothelium-derived nitric oxide formation to effects of vasoconstrictor agents neuropeptide Y, clonidine, and ergonovine on coronary vascular resistance.
Topics: Animals; Arginine; Blood Pressure; Clonidine; Coronary Circulation; Dogs; Ergonovine; Female; Heart Rate; Male; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Vascular Resistance; Vasoconstrictor Agents | 1994 |
Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
Topics: Amino Acid Oxidoreductases; Analysis of Variance; Animals; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Brain; Creatinine; Diet, Sodium-Restricted; Epinephrine; Heart Rate; Hypertension; Imidazoles; Kidney; Losartan; Male; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Phentolamine; Rats; Rats, Wistar; Reference Values; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Tetrazoles; Weight Gain | 1995 |
Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
Topics: Amino Acid Sequence; Animals; Arginine; Blood Pressure; Dose-Response Relationship, Drug; In Vitro Techniques; Kidney; Male; Molecular Sequence Data; Muscle Contraction; Muscle, Smooth; Neuropeptide Y; Perfusion; Rabbits; Rats; Rats, Inbred SHR; Receptors, Neuropeptide Y; Vas Deferens | 1995 |
Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP 3226.
Topics: Adipocytes; Amino Acid Sequence; Animals; Arginine; Brain; Calcium; CHO Cells; Cricetinae; Dogs; Humans; Kidney; Male; Molecular Sequence Data; Neuroblastoma; Neuropeptide Y; Peptide Fragments; Rabbits; Rats; Receptors, Neuropeptide Y; Stereoisomerism; Substrate Specificity; Tumor Cells, Cultured | 1995 |
Effect of combined nitric oxide inhalation and NG-nitro-L-arginine infusion in porcine endotoxin shock.
Topics: Administration, Inhalation; Animals; Arginine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelins; Escherichia coli Infections; Female; Infusions, Intravenous; Male; Neuropeptide Y; Nitric Oxide; Nitroarginine; Shock, Septic; Specific Pathogen-Free Organisms; Swine | 1995 |
Inhibitory effects of nicorandil on sympathetic coronary vasoconstriction.
Topics: Animals; Arginine; Coronary Vessels; Dogs; Electric Stimulation; Neuropeptide Y; Niacinamide; Nicorandil; Nitroarginine; Nitroglycerin; Norepinephrine; Sympathetic Nervous System; Vascular Resistance; Vasoconstriction | 1994 |
Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia.
Topics: Adrenocorticotropic Hormone; Adult; Arginine; Arginine Vasopressin; Corticotropin-Releasing Hormone; Female; Fibromyalgia; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Middle Aged; Neuropeptide Y; Pituitary-Adrenal System | 1994 |
Co-transmission from autonomic vasodilator neurons supplying the guinea pig uterine artery.
Topics: Animals; Arginine; Arteries; Autonomic Nervous System; Electric Stimulation; Female; Guinea Pigs; Naloxone; Neurons; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Scopolamine; Somatostatin; Uterus; Vasoactive Intestinal Peptide; Vasodilation | 1993 |
Modulation of bradykinin-induced plasma extravasation in the rat knee joint by sympathetic co-transmitters.
Topics: Adenosine; Adenosine Triphosphate; Animals; Antihypertensive Agents; Arginine; Arthritis; Bradykinin; Dinoprostone; Male; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Phenethylamines; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Sympathetic Nervous System | 1993 |
Endothelial regulation of coronary vascular tone in vitro: contribution of endothelin receptor subtypes and nitric oxide.
Topics: Amino Acid Sequence; Animals; Arginine; Coronary Vessels; Endothelins; Endothelium, Vascular; In Vitro Techniques; Molecular Sequence Data; Neuropeptide Y; Nitric Oxide; Nitroarginine; Peptides, Cyclic; Receptors, Endothelin; Swine | 1993 |
Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-I, angiotensin II and neuropeptide-Y, but not that caused by NG-nitro-L-arginine methyl ester, in conscious rats.
Topics: Angiotensin II; Animals; Arginine; Calcitonin Gene-Related Peptide; Carotid Arteries; Dose-Response Relationship, Drug; Endothelins; Magnesium; Magnesium Sulfate; Male; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred Strains; Vasoconstriction | 1993 |
Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock.
Topics: Administration, Inhalation; Animals; Arginine; Blood Gas Analysis; Blood Pressure; Endothelins; Female; Hemodynamics; Hypertension, Pulmonary; Male; Neuropeptide Y; Nitric Oxide; Nitroarginine; Norepinephrine; Pulmonary Circulation; Pulmonary Gas Exchange; Shock, Septic; Swine; Vascular Resistance | 1993 |
Efficient amidation of C-peptide deleted NPY precursors by non-endocrine cells is affected by the presence of Lys-Arg at the C-terminus.
Topics: 3T3 Cells; Amides; Amino Acid Sequence; Animals; Arginine; Blotting, Northern; Cell Line; CHO Cells; Cricetinae; Humans; Kidney; Lysine; Mice; Molecular Sequence Data; Mutagenesis, Site-Directed; Neuropeptide Y; Peptide Fragments; Protein Precursors; Transfection | 1993 |
Transient cerebral vasodilatory effect of neuropeptide Y mediated by nitric oxide.
Topics: Animals; Arginine; Blood Pressure; Brain Chemistry; Carotid Arteries; Cats; Cerebrovascular Circulation; Female; Injections, Intra-Arterial; Male; Neuropeptide Y; Nitric Oxide; omega-N-Methylarginine; Oxygen Consumption; Vasodilation | 1993 |
L-arginine/nitric oxide amplifies the magnitude and duration of the luteinizing hormone surge induced by estrogen: involvement of neuropeptide Y.
Topics: Animals; Arginine; Base Sequence; Estradiol; Female; Gonadotropin-Releasing Hormone; Hypothalamus, Middle; Luteinizing Hormone; Molecular Sequence Data; Neuropeptide Y; Nitric Oxide; Oligonucleotides, Antisense; Ovariectomy; Preoptic Area; Rats | 1996 |
Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
Topics: Animals; Arginine; Cattle; Dogs; Drug Evaluation, Preclinical; Electric Stimulation; Female; Male; Neuropeptide Y; Radioligand Assay; Rats; Receptors, Neuropeptide Y; Reserpine; Stereoisomerism; Swine; Sympathetic Nervous System; Vasoconstriction | 1995 |
Cyclic GMP regulates activation of phosphoinositidase C by bradykinin in sensory neurons.
Topics: Animals; Arginine; Bradykinin; Cells, Cultured; Cyclic GMP; Dibutyryl Cyclic GMP; Enzyme Activation; Ganglia, Spinal; Inositol 1,4,5-Trisphosphate; Neurons, Afferent; Neuropeptide Y; Nitric Oxide Synthase; Nitroarginine; Phosphoric Diester Hydrolases; Rats | 1996 |
Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.
Topics: Amino Acid Sequence; Arginine; Binding Sites; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Neuropeptide Y; Receptors, Neuropeptide Y; Structure-Activity Relationship | 1996 |
Comparative autoradiographic distribution of neuropeptide Y Y1 receptors visualized with the Y1 receptor agonist [125I][Leu31,Pro34]PYY and the non-peptide antagonist [3H]BIBP3226.
Topics: Animals; Arginine; Autoradiography; Iodine Radioisotopes; Male; Neuropeptide Y; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Tritium | 1996 |
Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats.
Topics: Anesthesia, General; Animals; Arginine; Corticosterone; Eating; Female; Glucose; Injections, Intraventricular; Insulin; Neuropeptide Y; Rats; Rats, Zucker; Stimulation, Chemical | 1996 |
Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.
Topics: Animals; Arginine; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Neuropeptide Y; Receptors, Neuropeptide Y; Sympathetic Nervous System; Vasoconstriction; Venae Cavae | 1995 |
The functional investigation of a human adenocarcinoma cell line, stably transfected with the neuropeptide Y Y1 receptor.
Topics: Adrenergic alpha-Agonists; Arginine; Clonidine; HT29 Cells; Humans; Iodine Radioisotopes; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide YY; Peptides; Receptors, Neuropeptide Y; Somatostatin; Stimulation, Chemical; Transfection; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 1996 |
Effects of the neuropeptide Y (NPY)-receptor antagonist BIBP3226 on vascular NPY-receptors with different ligand requirements.
Topics: Abdominal Muscles; Animals; Arginine; Blood Vessels; Guinea Pigs; Humans; In Vitro Techniques; Ligands; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Receptors, Neuropeptide Y; Vena Cava, Inferior | 1996 |
Presence of neuropeptide Y Y1 receptor mediating vasoconstriction in human cerebral arteries.
Topics: Arginine; Base Sequence; Cerebral Arteries; DNA Primers; Dose-Response Relationship, Drug; Electrophoresis, Agar Gel; Humans; Molecular Sequence Data; Neuropeptide Y; Polymerase Chain Reaction; Receptors, Neuropeptide Y; RNA, Messenger; Vasoconstriction | 1996 |
Contractile effects of neuropeptide Y in human subcutaneous resistance arteries are mediated by Y1 receptors.
Topics: Arginine; Arteries; Dose-Response Relationship, Drug; Humans; Neuropeptide Y; Polymerase Chain Reaction; Receptors, Neuropeptide Y; RNA, Messenger; Vasoconstriction | 1996 |
Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.
Topics: Animals; Arginine; Arteries; Blood Pressure; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide YY; Peptides; Phenylephrine; Rats; Rats, Wistar; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide Y; Vasoconstrictor Agents | 1996 |
Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptor.
Topics: Adrenergic alpha-Agonists; Arginine; Drug Synergism; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Norepinephrine; Oligonucleotides, Antisense; Polymerase Chain Reaction; Receptors, Neuropeptide Y; RNA, Messenger; Transcription, Genetic | 1996 |
In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
Topics: Animals; Arginine; Arteries; Blood Vessels; Cats; Dose-Response Relationship, Drug; Hindlimb; Male; Microcirculation; Muscle, Skeletal; Neuropeptide Y; Receptors, Neuropeptide Y; Regional Blood Flow; Sympathectomy; Vascular Resistance; Vasoconstrictor Agents; Veins | 1997 |
Does the neuropeptide Y Y1 receptor contribute to blood pressure control in the spontaneously hypertensive rat?
Topics: Animals; Arginine; Blood Pressure; Electric Stimulation; Heart Rate; Hypertension; Male; Neuropeptide Y; Peripheral Nerves; Phenylephrine; Prazosin; Rats; Rats, Inbred SHR; Receptors, Neuropeptide Y; Stress, Physiological; Tyramine | 1997 |
Modeling the G-protein-coupled neuropeptide Y Y1 receptor agonist and antagonist binding sites.
Topics: Amino Acid Sequence; Animals; Arginine; Binding Sites; Cattle; Computer Simulation; GTP-Binding Proteins; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Neuropeptide Y; Protein Conformation; Protein Engineering; Receptors, Neuropeptide Y | 1997 |
Neuropeptide Y-mediated pressor responses following high-frequency stimulation of the rat sympathetic nervous system.
Topics: Amino Acid Sequence; Animals; Arginine; Blood Pressure; Electric Stimulation; Male; Molecular Sequence Data; Neuropeptide Y; Phenoxybenzamine; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 1997 |
Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Topics: Animals; Arginine; Kidney; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Regional Blood Flow | 1997 |
Inhibition of stimulated cyclic AMP production by multiple neuropeptide Y receptors in the rat brainstem.
Topics: Animals; Arginine; Colforsin; Cyclic AMP; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Solitary Nucleus | 1997 |
Coronary vasoconstrictive effects of neuropeptide Y and their modulation by the ATP-sensitive potassium channel in anesthetized dogs.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arginine; Coronary Vessels; Dogs; Female; Male; Neuropeptide Y; Norepinephrine; Potassium Channels; Receptors, Neuropeptide Y; Vascular Resistance; Vasoconstriction | 1997 |
The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
Topics: Animals; Arginine; Blood Vessels; Electric Stimulation; Female; Male; Neuropeptide Y; Receptors, Neuropeptide Y; Swine; Sympathetic Nervous System | 1997 |
The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y.
Topics: Animals; Arginine; Biological Assay; Dogs; Dose-Response Relationship, Drug; Female; Humans; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides; Receptors, Neuropeptide Y; Saphenous Vein; Species Specificity; Swine; Vasoconstriction | 1997 |
BIBP 3226, suramin and prazosin identify neuropeptide Y, adenosine 5'-triphosphate and noradrenaline as sympathetic cotransmitters in the rat arterial mesenteric bed.
Topics: Adenosine Triphosphate; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Arginine; Electric Stimulation; Mesenteric Arteries; Neuropeptide Y; Norepinephrine; Prazosin; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Suramin; Sympathetic Nervous System | 1997 |
Non-competitive binding of the nonpeptide antagonist BIBP3226 to rat forebrain neuropeptide Y1 receptors.
Topics: Animals; Arginine; Binding, Competitive; Guanylyl Imidodiphosphate; Half-Life; In Vitro Techniques; Membranes; Nerve Tissue Proteins; Neuropeptide Y; Prosencephalon; Proteins; Radioligand Assay; Rats; Receptors, Neuropeptide Y | 1997 |
Stimulation of the sympathetic perimesenteric arterial nerves releases neuropeptide Y potentiating the vasomotor activity of noradrenaline: involvement of neuropeptide Y-Y1 receptors.
Topics: Animals; Arginine; Electric Stimulation; Guanethidine; Mesenteric Arteries; Nerve Endings; Neuropeptide Y; Norepinephrine; Oxidopamine; Perfusion; Rats; Receptors, Neuropeptide Y; Splanchnic Circulation; Sympathetic Nervous System | 1997 |
The rabbit ileum: a sensitive and selective preparation for the neuropeptide Y Y5 receptor.
Topics: Animals; Appetite Stimulants; Arginine; Binding, Competitive; Diamines; Humans; Ileum; Naphthalenes; Neuropeptide Y; Pancreatic Polypeptide; Peptide YY; Rabbits; Rats; Receptors, Neuropeptide Y; Structure-Activity Relationship | 1997 |
Time-dependent effects of ischaemia on neuropeptide Y mechanisms in pig renal vascular control in vivo.
Topics: Adrenergic alpha-Agonists; Animals; Arginine; Electric Stimulation; Female; Ischemia; Male; Neuropeptide Y; Norepinephrine; Peptide YY; Phenylephrine; Receptors, Neuropeptide Y; Renal Circulation; Reperfusion Injury; Swine; Sympathetic Nervous System; Time Factors; Vasoconstriction | 1997 |
The Y1 antagonist BIBP 3226 inhibits potentiation of methoxamine-induced vasoconstriction by neuropeptide Y.
Topics: Animals; Arginine; Drug Synergism; Hemodynamics; Male; Methoxamine; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Vasoconstriction; Vasoconstrictor Agents | 1997 |
Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea.
Topics: Animals; Arginine; Atropine; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Trachea | 1997 |
Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
Topics: Animals; Arginine; Electric Stimulation; Intestines; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Splanchnic Circulation; Sympathetic Nervous System; Vasoconstriction | 1998 |
Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Topics: Animals; Arginine; Binding Sites; Binding, Competitive; Brain; Iodine Radioisotopes; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1997 |
BIBP3226 inhibits neuropeptide Y and pancreatic polypeptide potentiated neurogenic vasoconstriction.
Topics: Animals; Arginine; In Vitro Techniques; Male; Neuropeptide Y; Pancreatic Polypeptide; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sympathetic Nervous System; Vasoconstriction | 1998 |
Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Arginine; Bicuculline; Circadian Rhythm; Electrophysiology; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Male; Neural Inhibition; Neuropeptide Y; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Neuropeptide Y; Suprachiasmatic Nucleus | 1998 |
Neuropeptide Y Y1 receptor blockade does not alter adrenergic nerve responses of the rat tail artery.
Topics: Animals; Arginine; Arteries; Electric Stimulation; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synaptic Transmission; Tail; Vasoconstriction | 1997 |
Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis.
Topics: Adenylyl Cyclases; Arginine; Cell Membrane; Chromones; Enzyme Inhibitors; Estrenes; Female; Humans; Inositol 1,4,5-Trisphosphate; Microvilli; Morpholines; Neuropeptide Y; Peptide YY; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Pregnancy; Protein Kinase C; Pyrrolidinones; Receptors, Neuropeptide Y; Trophoblasts; Type C Phospholipases | 1998 |
Neuropeptide Y lowers blood glucose in anaesthetized rats via a Y5 receptor subtype.
Topics: Animals; Arginine; Blood Glucose; Humans; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1998 |
Human neuropeptide YY1 receptors exert unequal control of the extracellular acidification rate in different cell lines.
Topics: Animals; Arginine; Cell Line; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Humans; Hydrogen-Ion Concentration; Kinetics; Neuropeptide Y; Radioligand Assay; Receptors, Neuropeptide Y; Tumor Cells, Cultured | 1998 |
Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
Topics: Animals; Arginine; Diazepam; Energy Intake; Feeding Behavior; Injections, Intraventricular; Male; Microinjections; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Starvation | 1998 |
Influence of age, hyperglycemia, leptin, and NPY on islet blood flow in obese-hyperglycemic mice.
Topics: Aging; Animals; Arginine; Blood Glucose; Body Weight; Hyperglycemia; Hyperinsulinism; Insulin; Insulin Secretion; Islets of Langerhans; Leptin; Mice; Mice, Inbred C57BL; Mice, Obese; Neuropeptide Y; Obesity; Organ Size; Pancreas; Perfusion; Phlorhizin; Proteins; Receptors, Leptin; Receptors, Neuropeptide Y; Regional Blood Flow | 1998 |
Increased neuropeptide Y pressor activity in Goldblatt hypertensive rats: in vivo studies with BIBP 3226.
Topics: Animals; Arginine; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension, Renovascular; Kidney; Male; Neuropeptide Y; Norepinephrine; Rats; Rats, Sprague-Dawley; Renal Artery | 1998 |
Mechanism of the acute pressor effect and bradycardia elicited by diaspirin crosslinked hemoglobin in anesthetized rats.
Topics: Animals; Arginine; Aspirin; Blood Pressure; Blood Substitutes; Bradycardia; Enzyme Inhibitors; Hemoglobins; Male; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Vagotomy | 1998 |
NPY Y1 antagonists: structure-activity relationships of arginine derivatives and hybrid compounds with arpromidine-like partial structures.
Topics: Arginine; Binding Sites; Calcium; Cell Line; Guanidines; Humans; Imidazoles; Models, Molecular; Neuropeptide Y; Receptors, Neuropeptide Y; Structure-Activity Relationship | 1998 |
Cloning and functional expression of the guinea pig neuropeptide Y Y2 receptor.
Topics: Amino Acid Sequence; Animals; Arginine; Cloning, Molecular; Conserved Sequence; COS Cells; Gene Expression; Guinea Pigs; Humans; In Vitro Techniques; Kinetics; Molecular Sequence Data; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Receptors, Neuropeptide Y; Recombinant Proteins; Sequence Homology, Amino Acid; Transfection | 1998 |
Characterization of NPY receptors mediating contraction in rat intramyocardial coronary arteries.
Topics: Animals; Arginine; Bridged Bicyclo Compounds, Heterocyclic; Coronary Vessels; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Indomethacin; Male; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide YY; Prostaglandins; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Receptors, Thromboxane; Vasoconstriction | 1998 |
Suppression of sensory C fiber-mediated contractions by neuropeptide Y Y1 receptors in the guinea pig bronchi.
Topics: Animals; Arginine; Bronchi; Bronchoconstriction; Guinea Pigs; Humans; In Vitro Techniques; Nerve Fibers; Neuropeptide Y; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y | 1998 |
Effect of BIBP3226 on inositol phosphate accumulation and cytosolic calcium level in control and NPY Y1 receptor expressing CHO-K1 cells.
Topics: Animals; Arginine; Calcium; Calcium-Transporting ATPases; CHO Cells; Cricetinae; Cyclic AMP; Cytosol; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Humans; Inositol Phosphates; Neuropeptide Y; Pertussis Toxin; Receptors, Neuropeptide Y; Recombinant Proteins; Thapsigargin; Type C Phospholipases; Virulence Factors, Bordetella | 1998 |
Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock.
Topics: Animals; Arginine; Blood Pressure; Disease Models, Animal; Heart Rate; Lipopolysaccharides; Male; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Shock, Hemorrhagic; Shock, Septic; Vasoconstriction | 1998 |
NPY receptor subtypes involved in the contraction of the proximal colon of the rat.
Topics: Animals; Arginine; Atropine; Colon; Diamines; Gene Expression; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Naphthalenes; Neuropeptide Y; Peptide Fragments; Peptide YY; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Tetrodotoxin | 1998 |
Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?
Topics: Animals; Arginine; Eating; Humans; Injections, Intraventricular; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Swine | 1998 |
The NPY Y1 receptor antagonist BIBP 3226 blocks NPY induced feeding via a non-specific mechanism.
Topics: Animals; Arginine; Dose-Response Relationship, Drug; Eating; Injections; Male; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Stereoisomerism | 1998 |
Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test.
Topics: Amygdala; Animal Communication; Animals; Anti-Anxiety Agents; Arginine; Behavior, Animal; Dose-Response Relationship, Drug; Male; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Social Behavior; Stereoisomerism | 1999 |
Adenosine 5'-triphosphate and neuropeptide Y are co-transmitters in conjunction with noradrenaline in the human saphenous vein.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Anti-Anxiety Agents; Arginine; Blood Vessels; Humans; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Prazosin; Purinergic Antagonists; Receptors, Neuropeptide Y; Receptors, Purinergic; Saphenous Vein; Suramin; Sympathetic Nervous System; Vasomotor System | 1999 |
A comparative study of the effects of nitric oxide and carbon monoxide on the in vivo release of gonadotropin-releasing hormone and neuropeptide Y from rat hypothalamus during the estradiol-induced luteinizing hormone surge: estimation by push-pull perfus
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Carbon Monoxide; Catheterization; Circadian Rhythm; Cyclic GMP; Estradiol; Female; Gonadotropin-Releasing Hormone; Hypothalamus; Luteinizing Hormone; Median Eminence; Neuropeptide Y; Nitric Oxide; Preoptic Area; Rats; Rats, Wistar | 1999 |
Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
Topics: Animals; Arginine; Eating; Feeding Behavior; Humans; Injections, Intraventricular; Male; Mice; Neuropeptide Y; Peptides, Cyclic; Psychomotor Performance; Receptors, Neuropeptide; Receptors, Neuropeptide Y | 1999 |
Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Topics: Animals; Arginine; Dinoprost; Drug Synergism; Endothelin-1; Endothelium, Vascular; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Neuropeptide Y; Nifedipine; Norepinephrine; Peptide Fragments; Potassium Chloride; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Serotonin; Vasoconstriction | 1999 |
Neuropeptide Y and ATP interact to control renovascular resistance in the rat.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Arginine; Culture Techniques; Kidney; Male; Neuropeptide Y; Norepinephrine; Phentolamine; Pressoreceptors; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Sensitivity and Specificity; Vascular Resistance; Vasoconstriction | 1999 |
NPY receptor subtype in the rabbit isolated ileum.
Topics: Animals; Arginine; CHO Cells; Cricetinae; Humans; Ileum; In Vitro Techniques; Male; Muscle Contraction; Naphthalenes; Neuropeptide Y; Pancreatic Polypeptide; Peptide YY; Pyrimidines; Rabbits; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Tetrodotoxin | 1999 |
Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampus in vitro via different NPY receptor subtypes.
Topics: Animals; Anticonvulsants; Arginine; Cerebral Cortex; Evoked Potentials; Hippocampus; Male; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 1999 |
Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
Topics: Agatoxins; Animals; Arginine; Autoreceptors; Biological Transport; Calcium Channel Blockers; Hypothalamus; Ligands; Male; Naphthalenes; Neuropeptide Y; Nifedipine; omega-Conotoxin GVIA; omega-Conotoxins; Organ Culture Techniques; Peptide Fragments; Peptides; Peptides, Cyclic; Potassium; Pyrimidines; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Spider Venoms | 1999 |
The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
Topics: Animals; Arginine; Arginine Vasopressin; Corticotropin-Releasing Hormone; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Hypothalamus; Male; Neuropeptide Y; Peptides; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Somatostatin | 1999 |
The involvement of neuropeptide Y Y1 receptors in the blood pressure baroreflex: studies with BIBP 3226 and BIBO 3304.
Topics: Animals; Arginine; Baroreflex; Blood Pressure; Cardiovascular Agents; Carotid Arteries; Cats; Dose-Response Relationship, Drug; Ligation; Neuropeptide Y; Receptors, Neuropeptide Y | 1999 |
ATP release and degradation in the kidney: modulatory role of neuropeptide Y (NPY).
Topics: Adenosine Triphosphate; Animals; Arginine; Kidney; Neuropeptide Y; Rats | 1999 |
Activation of G proteins by neuropeptide Y and gamma-aminobutyric acid(B) receptor agonists in rat cerebral cortical membranes through distinct modes of action.
Topics: Animals; Arginine; Biotransformation; Cell Membrane; Cerebral Cortex; GABA-B Receptor Agonists; GTP Phosphohydrolases; GTP-Binding Proteins; Guanosine Triphosphate; Magnesium Chloride; Male; Neuropeptide Y; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stimulation, Chemical | 1999 |
BIIE0246: a selective and high affinity neuropeptide Y Y(2) receptor antagonist.
Topics: Animals; Arginine; Benzazepines; Binding, Competitive; Cell Line; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Humans; Iodine Radioisotopes; Male; Muscle Contraction; Neuropeptide Y; Radioligand Assay; Rats; Receptors, Neuropeptide Y; Tumor Cells, Cultured; Vas Deferens | 1999 |
Actions of neuropeptide Y on the rat adrenal cortex.
Topics: Adrenal Cortex; Adrenergic beta-Antagonists; Aldosterone; Animals; Arginine; Atenolol; Catecholamines; Neuropeptide Y; Pancreatic Polypeptide; Rats; Receptors, Neuropeptide Y; RNA, Messenger; Steroids | 2000 |
Renal and cardiovascular role of the neuropeptide Y Y1 receptor in ischaemic heart failure rats.
Topics: Animals; Arginine; Blood Pressure; Cardiovascular System; Decerebrate State; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; In Vitro Techniques; Kidney; Male; Myocardial Ischemia; Neuropeptide Y; Norepinephrine; Potassium; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Renal Artery; Sodium | 1999 |
Structure-activity analysis of N-acetyl [Leu(28,31)] NPY 24-36: a potent neuropeptide Y Y(2) receptor agonist.
Topics: Amino Acid Substitution; Animals; Arginine; Dose-Response Relationship, Drug; Female; Lysine; Neural Inhibition; Neuropeptide Y; Peptide Fragments; Protein Structure, Secondary; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Structure-Activity Relationship; Vagus Nerve | 1999 |
Molecular dynamics of NPY Y1 receptor activation.
Topics: Arginine; Binding Sites; Humans; In Vitro Techniques; Ligands; Models, Molecular; Neuropeptide Y; Pancreatic Polypeptide; Peptide YY; Protein Conformation; Receptors, Neuropeptide Y; Static Electricity; Thermodynamics | 1999 |
Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices.
Topics: Action Potentials; Animals; Anti-Anxiety Agents; Arginine; Binding, Competitive; Epilepsy; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Male; Neuropeptide Y; Patch-Clamp Techniques; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synapses | 2000 |
Orexin-induced food intake involves neuropeptide Y pathway.
Topics: Animals; Arginine; Carrier Proteins; Eating; Hypothalamus; Intracellular Signaling Peptides and Proteins; Male; Neural Pathways; Neuropeptide Y; Neuropeptides; Orexin Receptors; Orexins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Receptors, Neuropeptide Y | 2000 |
Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.
Topics: Arginine; Arteries; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Skin; Vasodilation | 2000 |
Modulatory role of neuropeptides in seizures induced in rats by stimulation of glutamate receptors.
Topics: Animals; Anticonvulsants; Arginine; Convulsants; Kainic Acid; Male; Neuropeptide Y; Neuropeptides; Octreotide; Pentylenetetrazole; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, Neuropeptide Y; Receptors, Somatostatin; Seizures; Somatostatin | 2000 |
Neuropeptide Y induced increase of cytosolic and nuclear Ca2+ in heart and vascular smooth muscle cells.
Topics: Animals; Arginine; Calcium; Calcium Channels, L-Type; Cell Nucleus; Chick Embryo; Cytosol; Dose-Response Relationship, Drug; Humans; Muscle, Smooth, Vascular; Myocardium; Neuropeptide Y | 2000 |
Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release.
Topics: Animals; Arginine; Benzazepines; Hypothalamus; In Vitro Techniques; Male; Neuropeptide Y; Potassium; Rats; Rats, Wistar; Receptors, Neuropeptide Y | 2000 |
Electroconvulsive stimuli enhance both neuropeptide Y receptor Y1 and Y2 messenger RNA expression and levels of binding in the rat hippocampus.
Topics: Animals; Anti-Anxiety Agents; Arginine; Autoradiography; Down-Regulation; Electric Stimulation Therapy; Epilepsy; Gene Expression; Hippocampus; In Situ Hybridization; Iodine Radioisotopes; Male; Neuropeptide Y; Radioligand Assay; Rats; Rats, Wistar; Receptors, Neuropeptide Y; RNA, Messenger; Seizures | 2000 |
Evidence for Y1-receptor-mediated facilitatory, modulatory cotransmission by NPY in the rat anococcygeus muscle.
Topics: Animals; Arginine; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Neuropeptide Y; Norepinephrine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2000 |
Structure-activity relationships of neuropeptide Y Y1 receptor antagonists related to BIBP 3226.
Topics: Animals; Arginine; Drug Design; Humans; Kinetics; Leukemia, Erythroblastic, Acute; Molecular Conformation; Molecular Structure; Neuropeptide Y; Receptors, Neuropeptide Y; Structure-Activity Relationship; Swine; Tumor Cells, Cultured | 2000 |
Characterization of neuropeptide Y-mediated corticotropin-releasing factor synthesis and release from human placental trophoblasts.
Topics: Arginine; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Chelating Agents; Corticotropin-Releasing Hormone; Egtazic Acid; Enzyme Activation; Female; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neuropeptide Y; Pertussis Toxin; Pregnancy; Receptors, Neuropeptide Y; Trophoblasts; Virulence Factors, Bordetella | 2000 |
Effects of a selective neuropeptide Y Y(1) receptor antagonist BIBP 3226 on double peaked vasoconstrictor responses to periarterial nerve stimulation in canine splenic arteries.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Anti-Anxiety Agents; Arginine; Dogs; Drug Interactions; Electric Stimulation; Female; In Vitro Techniques; Male; Nerve Tissue; Neuropeptide Y; Norepinephrine; Prazosin; Receptors, Neuropeptide Y; Splenic Artery; Vasoconstriction | 2000 |
Dissociation of potentiation of Leu31 Pro34 neuropeptide Y on adrenergic and purinergic transmission in isolated canine splenic artery.
Topics: Adenosine Triphosphate; Animals; Arginine; Dogs; Electric Stimulation; Female; In Vitro Techniques; Male; Neuropeptide Y; Norepinephrine; Prazosin; Receptors, Adrenergic; Receptors, Neuropeptide Y; Receptors, Purinergic; Splenic Artery; Synaptic Transmission; Vasoconstriction | 2000 |
Regulation of food intake by neuropeptide Y in goldfish.
Topics: Animals; Anti-Anxiety Agents; Arginine; Body Weight; Brain Chemistry; Diet; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Female; Food Deprivation; Gene Expression; Goldfish; Growth Hormone; Injections, Intraventricular; Male; Neuropeptide Y; Receptors, Neuropeptide Y; RNA, Messenger; Third Ventricle | 2000 |
Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Arginine; Arteries; Calcium Channel Blockers; Calcium Channels; Cold Temperature; Ear; Electric Stimulation; Endothelium, Vascular; Enzyme Inhibitors; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Nitric Oxide Synthase; Norepinephrine; Phentolamine; Purinergic Antagonists; Rabbits; Receptors, Neuropeptide Y; Skin; Sympathetic Nervous System; Vasoconstriction; Verapamil | 2000 |
Neuropeptide Y is a cotransmitter with norepinephrine in guinea pig inferior mesenteric vein.
Topics: Adrenergic alpha-Antagonists; Animals; Arginine; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Male; Mesenteric Veins; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Reserpine; Sympathetic Nervous System; Vasoconstriction | 2000 |
Effects of the neuropeptide Y Y(2) receptor antagonist BIIE0246 on presynaptic inhibition by neuropeptide Y in rat hippocampal slices.
Topics: Animals; Arginine; Benzazepines; Binding, Competitive; Electrophysiology; Hippocampus; In Vitro Techniques; Male; Neural Inhibition; Neuropeptide Y; Rats; Receptors, Neuropeptide Y; Receptors, Presynaptic; Synapses | 2000 |
Role of neuropeptide Y in the development of two-kidney, one-clip renovascular hypertension in the rat.
Topics: Animals; Arginine; Blood Pressure Determination; Disease Models, Animal; Hemodynamics; Hypertension, Renal; Injections, Intravenous; Kidney; Male; Neuropeptide Y; Probability; Rats; Rats, Sprague-Dawley; Reference Values; Renin | 2000 |
Acceleration of pubertal development following central blockade of the Y1 subtype of neuropeptide Y receptors.
Topics: Aging; Animals; Arginine; Body Weight; Female; Hypothalamus; Luteinizing Hormone; Neuropeptide Y; Pituitary Gland; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Sexual Maturation; Vagina; Weight Gain | 2000 |
Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
Topics: Animals; Arginine; In Vitro Techniques; Male; Middle Cerebral Artery; Muscle, Smooth, Vascular; Neuropeptide Y; Rats; Rats, Long-Evans; Receptors, Neuropeptide Y; Vasoconstriction; Vasodilation | 2001 |
Constitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell lines.
Topics: Adenocarcinoma; Arginine; Colonic Neoplasms; Humans; Neuropeptide Y; Pancreatic Polypeptide; Peptides, Cyclic; Receptors, Neuropeptide Y; Receptors, Somatostatin; Reverse Transcriptase Polymerase Chain Reaction; RNA; Somatostatin; Structure-Activity Relationship; Tumor Cells, Cultured; Vasoactive Intestinal Peptide | 2001 |
Neuropeptide-Y in the paraventricular nucleus increases ethanol self-administration.
Topics: Alcohol Drinking; Animals; Arginine; Body Weight; Dose-Response Relationship, Drug; Ethanol; Hypothalamus; Male; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Long-Evans; Water | 2001 |
Neuropeptide Y functions as a neuroproliferative factor.
Topics: Animals; Arginine; Cell Count; Cell Division; Cells, Cultured; Epithelial Cells; Gene Targeting; Male; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neurons; Neuropeptide Y; Olfactory Mucosa; Olfactory Receptor Neurons; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinase C; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2001 |
Modest overexpression of neuropeptide Y in the brain leads to obesity after high-sucrose feeding.
Topics: Aging; Animals; Arginine; Brain; Cyclohexanes; Dietary Sucrose; Energy Intake; Homozygote; Humans; Mice; Mice, Knockout; Mice, Transgenic; Neuropeptide Y; Obesity; Phenotype; Promoter Regions, Genetic; Receptors, Neuropeptide Y; Reference Values; Thy-1 Antigens; Xanthenes | 2001 |
Gastric distension-induced pyloric relaxation: central nervous system regulation and effects of acute hyperglycaemia in the rat.
Topics: Acute Disease; Animals; Arginine; Catheterization; Central Nervous System; Electrophysiology; Hyperglycemia; Hypothalamus; Injections, Intraventricular; Male; Muscle Relaxation; Muscle, Smooth; Neuropeptide Y; Pylorus; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reference Values; Stomach | 2001 |
The central effects of orexin-A in the hypothalamic-pituitary-adrenal axis in vivo and in vitro in male rats.
Topics: Adrenal Glands; Adrenocorticotropic Hormone; Animals; Arginine; Arginine Vasopressin; Carrier Proteins; Corticosterone; Corticotropin-Releasing Hormone; Culture Techniques; Hypothalamus; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Kinetics; Male; Neuropeptide Y; Neuropeptides; Norepinephrine; Orexins; Pituitary Gland; Rats; Rats, Wistar | 2001 |
Vascular pharmacology of BIIE0246, the first selective non-peptide neuropeptide Y Y(2) receptor antagonist, in vivo.
Topics: Animals; Arginine; Benzazepines; Blood Flow Velocity; Blood Pressure; Dose-Response Relationship, Drug; Female; Heart Rate; Kidney; Male; Neuropeptide Y; Peptide YY; Receptors, Neuropeptide Y; Spleen; Swine; Vasoconstriction | 2001 |
Interactions between orexin A, NPY and galanin in the control of food intake of the goldfish, Carassius auratus.
Topics: Animals; Arginine; Carrier Proteins; Dose-Response Relationship, Drug; Drug Interactions; Eating; Feeding Behavior; Galanin; Goldfish; Humans; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Male; Neuropeptide Y; Neuropeptides; Orexin Receptors; Orexins; Peptide Fragments; Rats; Receptors, G-Protein-Coupled; Receptors, Galanin; Receptors, Neuropeptide; Receptors, Neuropeptide Y; RNA, Messenger; Signal Transduction; Time Factors | 2001 |
Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo.
Topics: Amides; Animals; Arginine; Benzazepines; Male; Neuropeptide Y; Receptors, Neuropeptide Y; Spleen; Swine | 2001 |
Effects of BIBP3226 and BIBP3435 on cytosolic calcium in neuropeptide Y Y1 receptor-transfected Chinese hamster ovary cells and wild type CHO-K1 cells.
Topics: Animals; Arginine; Calcium; CHO Cells; Cricetinae; Cytosol; Kinetics; Neuropeptide Y; Receptors, Neuropeptide Y; Stereoisomerism; Transfection | 2001 |
Involvement of NPY Y2 receptor subtype in the control of the spontaneous NO/GnRH release at the rat median eminence.
Topics: Animals; Anti-Anxiety Agents; Arginine; Benzazepines; Endothelium, Vascular; Estrous Cycle; Female; Gonadotropin-Releasing Hormone; Median Eminence; Neuropeptide Y; Nitric Oxide; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2001 |
Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor.
Topics: Arginine; Calcium; Cell Line; Concanavalin A; Endosomes; Green Fluorescent Proteins; GTP-Binding Proteins; Humans; Hypertonic Solutions; Kinetics; Luminescent Proteins; Models, Biological; Neuropeptide Y; Phosphorylation; Protein Transport; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Signal Transduction; Spectrometry, Fluorescence; Stress, Mechanical; Sucrose; Transfection | 2002 |
Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers.
Topics: Animals; Appetite; Arginine; Body Temperature; Brain; Carrier Proteins; Eating; Ghrelin; Growth Hormone; Immunohistochemistry; Injections, Intraventricular; Intracellular Signaling Peptides and Proteins; Male; Neurons; Neuropeptide Y; Neuropeptides; Oligopeptides; Orexins; Peptide Hormones; Peptides; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 2002 |
The feeding response to melanin-concentrating hormone is attenuated by antagonism of the NPY Y(1)-receptor in the rat.
Topics: Animals; Arginine; Drug Combinations; Eating; Hypothalamic Hormones; Male; Melanins; Neuropeptide Y; Peptides, Cyclic; Pituitary Hormones; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2002 |
Role of neuropeptide Y Y(2) receptors in modulation of cardiac parasympathetic neurotransmission.
Topics: Animals; Arginine; Benzazepines; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Heart; Mice; Mice, Knockout; Myocardium; Neuropeptide Y; Neurotransmitter Agents; Parasympathetic Nervous System; Peptide Fragments; Receptors, Neuropeptide Y; Vagus Nerve | 2002 |
Separate modulation of neuropeptide Y1 receptor on purinergic and on adrenergic neuroeffector transmission in canine splenic artery.
Topics: Animals; Anti-Anxiety Agents; Arginine; Dogs; Electric Stimulation; Female; Male; Neuroeffector Junction; Neuropeptide Y; Receptors, Adrenergic; Receptors, Neuropeptide Y; Receptors, Purinergic; Splenic Artery; Vasoconstriction | 2001 |
Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Topics: Animals; Arginine; Benzazepines; Electric Stimulation; Female; Heart Rate; Kidney; Male; Neural Inhibition; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Peptide YY; Receptors, Neuropeptide Y; Renal Circulation; Spleen; Swine; Sympathetic Nervous System; Yohimbine | 2002 |
The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test.
Topics: Animals; Antidepressive Agents; Arginine; Benzazepines; Depression; Drug Evaluation, Preclinical; Immobilization; Male; Mice; Motor Activity; Neuropeptide Y; Peptide Fragments; Receptors, Neuropeptide Y; Swimming | 2002 |
Autoinhibitory function of the sympathetic prejunctional neuropeptide Y Y(2) receptor evidenced by BIIE0246.
Topics: Animals; Arginine; Benzazepines; Blood Flow Velocity; Blood Pressure; Electric Stimulation; Female; Heart Rate; Kidney; Male; Neuropeptide Y; Receptors, Neuropeptide Y; Renal Circulation; Reserpine; Spleen; Swine; Sympathetic Nervous System | 2002 |
Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat.
Topics: Animals; Arginine; Brain; Electron Spin Resonance Spectroscopy; Injections, Intra-Arterial; Injections, Intraventricular; Male; Neuropeptide Y; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stroke | 2002 |
Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig.
Topics: Amides; Animals; Arginine; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Guinea Pigs; Male; Neuropeptide Y; Receptors, Neuropeptide Y | 2002 |
Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors.
Topics: Acute Disease; Animals; Arginine; Body Temperature; Carrageenan; Disease Models, Animal; Freund's Adjuvant; Hot Temperature; Hyperalgesia; Injections, Spinal; Male; Motor Activity; Neurogenic Inflammation; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Spinal Cord | 2002 |
Reciprocal mutations of neuropeptide Y receptor Y2 in human and chicken identify amino acids important for antagonist binding.
Topics: Amino Acid Sequence; Animals; Arginine; Benzazepines; Binding Sites; Cattle; Chickens; Glutamine; Humans; Leucine; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Neuropeptide Y; Receptors, Neuropeptide Y; Rhodopsin; Sequence Alignment; Transfection | 2002 |
Neuropeptide Y Y(1) receptor regulates protein turnover and constitutive gene expression in hypertrophying cardiomyocytes.
Topics: Animals; Arginine; Cells, Cultured; Dactinomycin; Dose-Response Relationship, Drug; Gene Expression Regulation; Heart Ventricles; Humans; Male; Myosin Light Chains; Neuropeptide Y; Peptide Fragments; Protein Synthesis Inhibitors; Proteins; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Time Factors | 2002 |
Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
Topics: Animals; Arginine; Benzazepines; Dose-Response Relationship, Drug; Electric Stimulation; Epilepsy; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Male; Neuropeptide Y; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synaptic Transmission | 2002 |
The direct stimulation of Gi proteins by neuropeptide Y (NPY) in the rat left ventricle.
Topics: Animals; Antibodies; Arginine; Cell Membrane; Colforsin; Cyclic AMP; Drug Interactions; GTP Phosphohydrolases; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine Triphosphate; Heart Ventricles; Hydrolysis; Kinetics; Male; Neuropeptide Y; Rats; Rats, Wistar; Ventricular Function, Left | 2002 |
Effect of neuropeptide Y on inflammatory paw edema in the rat: involvement of peripheral NPY Y1 and Y5 receptors and interaction with dipeptidyl-peptidase IV (CD26).
Topics: Animals; Arginine; Cells, Cultured; Concanavalin A; Dipeptidyl Peptidase 4; Dose-Response Relationship, Drug; Edema; Hydrogen Peroxide; Inflammation; Isoleucine; Macrophages; Male; Neuropeptide Y; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Thiazoles | 2002 |
Molecular identification of the long isoform of the human neuropeptide Y Y5 receptor and pharmacological comparison with the short Y5 receptor isoform.
Topics: 5' Untranslated Regions; Alternative Splicing; Animals; Arginine; Base Sequence; Brain; Cloning, Molecular; Codon, Initiator; COS Cells; Humans; Molecular Sequence Data; Neuropeptide Y; Protein Biosynthesis; Protein Isoforms; Receptors, Neuropeptide Y; RNA, Messenger; Transcription, Genetic; Trinucleotide Repeats | 2003 |
Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y.
Topics: Animals; Arginine; Benzazepines; Disease Models, Animal; Disease Progression; Ganglia, Spinal; Hyperalgesia; Immune Sera; Ligation; Lumbosacral Region; Male; Medulla Oblongata; Microinjections; Nerve Crush; Neuropeptide Y; Pain Measurement; Pain Threshold; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Rhizotomy; Spinal Cord; Spinal Nerves | 2002 |
Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade.
Topics: Animals; Anticonvulsants; Arginine; Calcium; Electroshock; Extracellular Space; Hippocampus; Male; Microdialysis; Neuropeptide Y; Potassium Chloride; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Seizures | 2002 |
Cardiac function in neuropeptide Y Y4 receptor-knockout mice.
Topics: Animals; Arginine; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart; Heart Rate; Male; Mice; Mice, Knockout; Neuropeptide Y; Pancreatic Polypeptide; Parasympathetic Nervous System; Receptors, Neuropeptide Y; Vagus Nerve | 2002 |
Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats.
Topics: Animals; Anti-Anxiety Agents; Arginine; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Male; Neuropeptide Y; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2003 |
Neuropeptide Y inhibits double peaked vasoconstrictor responses to periarterial nerve stimulation primarily through prejunctional Y2 receptor subtype in canine splenic arteries.
Topics: Animals; Arginine; Benzazepines; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Female; In Vitro Techniques; Male; Nerve Fibers; Neuropeptide Y; Receptors, Neuropeptide Y; Splenic Artery; Vasoconstriction | 2002 |
Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Topics: Animals; Arginine; Benzazepines; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Cyclohexanes; Drug Interactions; Glutamic Acid; Hippocampus; Ionomycin; Ionophores; Neurons; Neuropeptide Y; omega-Agatoxin IVA; omega-Conotoxin GVIA; Peptide Fragments; Potassium Chloride; Rats; Rats, Wistar; Receptor Cross-Talk; Receptors, Neuropeptide Y; Synaptosomes; Xanthenes | 2003 |
Neuropeptide Y secretion from bovine chromaffin cells inhibits cyclic AMP accumulation.
Topics: Animals; Arginine; Cattle; Cells, Cultured; Chromaffin Cells; Chromatography, High Pressure Liquid; Colforsin; Culture Media, Conditioned; Cyclic AMP; In Vitro Techniques; Neuropeptide Y; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pertussis Toxin; Radioimmunoassay; Receptors, Neuropeptide Y | 2000 |
Nitric oxide-dependent in vitro secretion of amylase from innervated or chronically denervated parotid glands of the rat in response to isoprenaline and vasoactive intestinal peptide.
Topics: Adrenergic beta-Agonists; Amylases; Animals; Arginine; Autonomic Denervation; Bethanechol; Enzyme Inhibitors; Female; Gastrointestinal Agents; Guanylate Cyclase; In Vitro Techniques; Isoproterenol; Neuropeptide Y; Nitric Oxide; Nitric Oxide Synthase; Oxadiazoles; Parasympathomimetics; Parotid Gland; Quinoxalines; Rats; Rats, Sprague-Dawley; Vasoactive Intestinal Peptide | 2003 |
Neuropeptide Y and peptide YY inhibit excitatory synaptic transmission in the rat dorsal motor nucleus of the vagus.
Topics: Adrenergic Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Adrenergic Antagonists; Animals; Arginine; Cell Membrane; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Female; In Vitro Techniques; Male; Membrane Potentials; Neuropeptide Y; Patch-Clamp Techniques; Peptide YY; Rats; Rats, Sprague-Dawley; Reserpine; Synaptic Transmission; Vagus Nerve; Yohimbine | 2003 |
Effects of varying impulse number on cotransmitter contributions to sympathetic vasoconstriction in rat tail artery.
Topics: Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Arginine; Arteries; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Neuropeptide Y; Neurotransmitter Agents; Norepinephrine; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Suramin; Sympathetic Nervous System; Synaptic Transmission; Tail; Vasoconstriction; Vasoconstrictor Agents | 2003 |
Functional consequences of neuropeptide Y Y 2 receptor knockout and Y2 antagonism in mouse and human colonic tissues.
Topics: Animals; Arginine; Benzazepines; Colon; Electric Stimulation; Female; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Sex Characteristics; Tetrodotoxin | 2003 |
Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.
Topics: Alanine; Aminoisobutyric Acids; Animals; Arginine; Benzazepines; Brain; Carbon Radioisotopes; Cell Line; Iodine Radioisotopes; Male; Naphthalenes; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides, Cyclic; Pyrimidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Substrate Specificity; Time Factors; Transformation, Genetic | 2003 |
The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
Topics: Animals; Arginine; Capillary Permeability; Dose-Response Relationship, Drug; Edema; Female; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Neutrophils; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Regional Blood Flow; Skin | 2003 |
Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.
Topics: Amino Acid Sequence; Animals; Antigen-Presenting Cells; Arginine; Dose-Response Relationship, Immunologic; Encephalomyelitis, Autoimmune, Experimental; Epitopes, T-Lymphocyte; Female; Glycoproteins; Immunosuppressive Agents; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Molecular Sequence Data; Myelin-Oligodendrocyte Glycoprotein; Neuropeptide Y; Peptide Fragments; Receptors, Neuropeptide Y; RNA, Messenger; T-Lymphocytes; Th1 Cells | 2003 |
Neuropeptide Y enhances permeability across a rat aortic endothelial cell monolayer.
Topics: Animals; Anti-Anxiety Agents; Aorta; Arginine; Bradykinin; Bradykinin B2 Receptor Antagonists; Capillary Permeability; Cells, Cultured; Cyclic AMP; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Histamine; Indomethacin; Male; Neuropeptide Y; Nitric Oxide; omega-N-Methylarginine; Peptide Fragments; Peptide YY; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factor A | 2004 |
Neuropeptide Y (NPY) delays the oestrogen-induced luteinizing hormone (LH) surge in the ovariectomized ewe: further evidence that NPY has a predominant negative effect on LH secretion in the ewe.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Cross-Over Studies; Down-Regulation; Estradiol; Estrus; Female; Gonadotropin-Releasing Hormone; In Situ Hybridization; Luteinizing Hormone; Neuropeptide Y; Ovariectomy; Ovulation; Progesterone; Receptors, Neuropeptide Y; Receptors, Progesterone; RNA, Messenger; Sheep | 2003 |
Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis.
Topics: Animals; Arginine; Body Weight; Eating; Energy Metabolism; Gastric Mucosa; Gene Expression; Ghrelin; Hyperphagia; Hypothalamus; Leptin; Male; Nerve Tissue Proteins; Neuropeptide Y; Peptide Hormones; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Thyrotoxicosis; Triiodothyronine | 2003 |
Neuropeptide Y promotes beta-cell replication via extracellular signal-regulated kinase activation.
Topics: Animals; Apoptosis; Arginine; Bromodeoxyuridine; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Fluorescent Antibody Technique; In Situ Nick-End Labeling; Insulin; Insulin Antagonists; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred ICR; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Neuropeptide Y; Receptors, Neuropeptide Y; Time Factors | 2004 |
Neuropeptide Y selectively potentiates alpha1-adrenoceptor-mediated contraction through Y1 receptor subtype in rat femoral artery.
Topics: Animals; Aorta, Thoracic; Arginine; Dose-Response Relationship, Drug; Drug Synergism; Femoral Artery; Gene Expression; Humans; Male; Muscle Contraction; Muscle, Smooth, Vascular; Neuropeptide Y; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Serotonin | 2003 |
Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism.
Topics: Analgesics; Animals; Arginine; Calcitonin Gene-Related Peptide; Capsaicin; Exocytosis; Fluorescent Antibody Technique; Ganglia, Spinal; In Vitro Techniques; Male; Neurons, Afferent; Neuropeptide Y; Nociceptors; Peptide Fragments; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, Drug; Receptors, Neuropeptide Y | 2004 |
Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.
Topics: Acetylcholine; Aged; Aged, 80 and over; Arginine; Atrial Appendage; Benzazepines; Electric Stimulation; Female; Heart Failure; Humans; Male; Middle Aged; Neuropeptide Y; Presynaptic Terminals; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Vasodilator Agents | 2004 |
Neuropeptide Y antagonism reduces reflex cutaneous vasoconstriction in humans.
Topics: Adult; Arginine; Blood Vessels; Cold Temperature; Drug Combinations; Fingers; Humans; Isotonic Solutions; Male; Neuropeptide Y; Norepinephrine; Propranolol; Reflex; Regional Blood Flow; Ringer's Solution; Skin; Skin Physiological Phenomena; Skin Temperature; Sympathetic Nervous System; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Vasomotor System; Yohimbine | 2004 |
Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
Topics: Animals; Arginine; Auditory Perception; Bradycardia; Conditioning, Psychological; Cues; Fear; Heart Rate; Male; Mice; Mice, Inbred C57BL; Neuropeptide Y; Receptors, Neuropeptide Y; Swine | 2004 |
Gender-modulated endogenous baseline neuropeptide Y Y1-receptor activation in the hindlimb of Sprague-Dawley rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Arginine; Blood Pressure; Blotting, Western; Female; Femoral Artery; Heart Rate; Hindlimb; Immunoassay; Male; Neuropeptide Y; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Regional Blood Flow; Sex Characteristics | 2005 |
Differential expression of Y receptors and signaling pathways in intestinal circular and longitudinal smooth muscle.
Topics: Animals; Arginine; Benzazepines; Calcium Channels; Cyclic AMP; Dose-Response Relationship, Drug; Muscle Contraction; Muscle, Smooth; Muscles; Neuropeptide Y; Peptide Fragments; Peptide YY; Pertussis Toxin; Protein Binding; Rabbits; Radioimmunoassay; Receptors, Neuropeptide Y; Signal Transduction; Time Factors | 2005 |
Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence.
Topics: Alcoholism; Animals; Arginine; Benzazepines; Brain; Brain Chemistry; Disease Models, Animal; Ethanol; Male; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Self Administration | 2005 |
Up-regulation of neuropeptide Y receptors in the hypothalamus of monosodium glutamate-lesioned Sprague-Dawley rats.
Topics: Animals; Arginine; Body Weight; Eating; Hypothalamus; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sodium Glutamate | 2004 |
Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain.
Topics: 2-Amino-5-phosphonovalerate; Animals; Arginine; Benzazepines; Bicuculline; Convulsants; Dentate Gyrus; Excitatory Postsynaptic Potentials; Hippocampus; Male; Mossy Fibers, Hippocampal; Neuropeptide Y; Patch-Clamp Techniques; Perforant Pathway; Pilocarpine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide Y; Status Epilepticus; Synaptic Transmission; Tetrodotoxin | 2005 |
Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Behavior, Animal; Disease Models, Animal; DNA, Antisense; Gene Expression Regulation; Genetic Vectors; Immunohistochemistry; Male; Maze Learning; Neuropeptide Y; Rats; Rats, Long-Evans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2005 |
Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats.
Topics: Adenosine Triphosphate; Aging; Animals; Arginine; Dose-Response Relationship, Drug; Electric Stimulation; Kidney; Male; Neuropeptide Y; Norepinephrine; Perfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Receptors, Purinergic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sympathetic Nervous System | 2005 |
Irreversible binding kinetics of neuropeptide Y ligands to Y2 but not to Y1 and Y5 receptors.
Topics: Animals; Arginine; Benzazepines; Binding, Competitive; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Kinetics; Ligands; Mice; Neuropeptide Y; Peptide YY; Receptors, Neuropeptide Y; Transfection | 2005 |
Neuropeptide Y and its receptor analogs differentially modulate the immunoreactivity for neuronal or endothelial nitric oxide synthase in the rat brain following focal ischemia with reperfusion.
Topics: Animals; Anti-Anxiety Agents; Arginine; Brain; Brain Ischemia; Cerebral Arteries; Immunohistochemistry; Male; Neurons; Neuropeptide Y; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reperfusion Injury; Temperature; Time Factors | 2005 |
Neuropeptide Y bioavailability is suppressed in the hindlimb of female Sprague-Dawley rats.
Topics: Aminopeptidases; Animals; Arginine; Benzazepines; Enzyme Inhibitors; Female; Hindlimb; Male; Mercaptoethanol; Muscle, Skeletal; Neuropeptide Y; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Regional Blood Flow | 2005 |
Ghrelin-induced stimulation of colonic propulsion is dependent on hypothalamic neuropeptide Y1- and corticotrophin-releasing factor 1 receptor activation.
Topics: Animals; Arginine; Brain; Colon; Corticotropin-Releasing Hormone; Gastrointestinal Motility; Ghrelin; Hypothalamus; Male; Microinjections; Neuropeptide Y; Neuroprotective Agents; Paraventricular Hypothalamic Nucleus; Peptide Fragments; Peptide Hormones; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Stimulation, Chemical | 2005 |
Influence of endogenous neuropeptide Y (NPY) on the sympathetic-parasympathetic interaction in the canine heart.
Topics: Animals; Arginine; Benzazepines; Blood Pressure; Catecholamines; Dogs; Electric Stimulation; Heart; Heart Rate; Myocardium; Nerve Fibers; Neuropeptide Y; Parasympathetic Nervous System; Receptors, Neuropeptide Y; Sympathetic Nervous System; Time Factors; Vagus Nerve | 2005 |
The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
Topics: Animals; Anticonvulsants; Arginine; Autoradiography; Benzazepines; Electric Stimulation; Electroencephalography; Electrophysiology; Excitatory Amino Acid Agonists; Hippocampus; In Vitro Techniques; Kainic Acid; Magnesium; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Rats; Receptors, Neuropeptide Y; Seizures; Synapses | 2005 |
Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors.
Topics: Analysis of Variance; Animals; Arginine; Benzazepines; Brain Stem; Cell Count; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Transporter 3; Female; Gastric Acid; Gastric Emptying; Gastric Mucosa; Hydrochloric Acid; Hydrogen-Ion Concentration; Immunohistochemistry; Mice; Mice, Knockout; Neurons; Neuropeptide Y; Peptide Fragments; Peptide YY; Proto-Oncogene Proteins c-fos; Receptors, Neuropeptide Y | 2005 |
Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis.
Topics: Animals; Arginine; Barium; Bee Venoms; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Interactions; Electric Stimulation; Excitatory Postsynaptic Potentials; Green Fluorescent Proteins; Hypothalamus; Immunohistochemistry; In Vitro Techniques; Membrane Potentials; Mice; Mice, Transgenic; Neural Inhibition; Neurons; Neuropeptide Y; Patch-Clamp Techniques; Peptide Fragments; Peptide YY; Potassium Channel Blockers; Pro-Opiomelanocortin | 2005 |
[Thyroid hormone and various other hormones regulate hypothalamic neuropeptide Y (NPY) expression and feeding behavior].
Topics: Animals; Arginine; Eating; Ghrelin; Hypothalamic Hormones; Hypothalamus; Insulin; Intracellular Signaling Peptides and Proteins; Leptin; Melanins; Nerve Tissue Proteins; Neuropeptide Y; Neuropeptides; Orexins; Peptide Hormones; Pituitary Hormones; Pro-Opiomelanocortin; Rats; Thyroid Hormones; Thyrotoxicosis; Triiodothyronine | 2006 |
Attenuation of capsaicin-evoked mechanical allodynia by peripheral neuropeptide Y Y1 receptors.
Topics: Analysis of Variance; Animals; Arginine; Behavior, Animal; Calcitonin Gene-Related Peptide; Capsaicin; Dose-Response Relationship, Drug; Drug Interactions; Hyperesthesia; Male; Neuropeptide Y; Pain Measurement; Peptide Fragments; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sensory Thresholds; Skin; Time Factors | 2006 |
Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
Topics: Animals; Arginine; Benzazepines; Blood Pressure; Blotting, Western; Electric Stimulation; Female; Hypertension; Immunohistochemistry; Mesenteric Arteries; Neuropeptide Y; Peripheral Vascular Diseases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Vasoconstriction; Vasodilation | 2006 |
Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Anti-Anxiety Agents; Arginine; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Immune Tolerance; Killer Cells, Natural; Male; Morphine; Morphine Dependence; Narcotics; Neuroimmunomodulation; Neuropeptide Y; Nucleus Accumbens; Rats; Rats, Inbred Lew; Receptors, Dopamine D1; Receptors, Neuropeptide Y; Spleen; Sympathetic Nervous System | 2006 |
Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami.
Topics: Action Potentials; Analysis of Variance; Animals; Animals, Newborn; Anticonvulsants; Arginine; Drug Administration Schedule; Gene Expression Regulation; Immunohistochemistry; In Vitro Techniques; Midline Thalamic Nuclei; Neuropeptide Y; Phosphopyruvate Hydratase; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Valproic Acid | 2006 |
Involvement of neuropeptide Y Y1 receptors in the regulation of LH and GH cells in the pituitary of the catfish, Clarias batrachus: an immunocytochemical study.
Topics: Animals; Anti-Anxiety Agents; Antibody Specificity; Arginine; Catfishes; Female; Growth Hormone; Immunohistochemistry; Luteinizing Hormone; Neuropeptide Y; Neurosecretory Systems; Pituitary Gland; Receptors, Neuropeptide Y; Reproduction | 2006 |
Neuropeptide Y mediates ghrelin-induced feeding in the goldfish, Carassius auratus.
Topics: Animals; Arginine; Brain; Feeding Behavior; Female; Ghrelin; Goldfish; Injections, Intraperitoneal; Injections, Intraventricular; Male; Neuropeptide Y; Peptide Hormones; Receptors, Neuropeptide Y; RNA, Messenger | 2006 |
Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Topics: Animals; Arginine; Benzazepines; Convulsants; Dentate Gyrus; Epilepsy, Temporal Lobe; Glutamic Acid; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mossy Fibers, Hippocampal; Neuronal Plasticity; Neuropeptide Y; Organ Culture Techniques; Patch-Clamp Techniques; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Species Specificity; Status Epilepticus; Synaptic Transmission | 2006 |
Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
Topics: Aequorin; Animals; Apoproteins; Arginine; Benzazepines; Binding, Competitive; Calcium Signaling; CHO Cells; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescent Dyes; GTP-Binding Protein alpha Subunits, Gq-G11; Ligands; Microscopy, Confocal; Neuropeptide Y; Peptide Fragments; Peptide YY; Protein Binding; Radioligand Assay; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Recombinant Proteins; Reproducibility of Results; Spectrometry, Fluorescence; Swine; Transfection | 2006 |
The effect of intrahippocampal injection of group II and III metobotropic glutamate receptor agonists on anxiety; the role of neuropeptide Y.
Topics: Amino Acids, Dicarboxylic; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Autoradiography; Dose-Response Relationship, Drug; Hippocampus; In Situ Hybridization; Male; Microinjections; Neuropeptide Y; Phosphoserine; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; RNA, Messenger | 2007 |
Receptor subtype-specific docking of Asp6.59 with C-terminal arginine residues in Y receptor ligands.
Topics: Amino Acid Sequence; Animals; Arginine; Chlorocebus aethiops; Conserved Sequence; COS Cells; Cricetinae; Humans; Ligands; Models, Molecular; Molecular Sequence Data; Neuropeptide Y; Pancreatic Polypeptide; Receptors, Neuropeptide Y | 2007 |
Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
Topics: Animals; Antidepressive Agents; Arginine; Avoidance Learning; Behavior, Animal; Benzazepines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Helplessness, Learned; Hippocampus; Injections, Intraventricular; Male; Neuropeptide Y; Peptide YY; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, G-Protein-Coupled; Receptors, Neuropeptide | 2007 |
Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
Topics: Animals; Arginine; Benzazepines; Dopamine; Male; Naphthalenes; Neostriatum; Neuropeptide Y; Peptide Fragments; Peptide YY; Potassium Chloride; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stimulation, Chemical; Synaptic Transmission; Tyrosine | 2007 |
Gastrointestinal hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development.
Topics: Animals; Arginine; Brain; Brain Chemistry; Cyclohexanes; Eating; Female; Folic Acid; Genes, Lethal; Genes, Synthetic; Ghrelin; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Mice, Transgenic; Neural Tube Defects; Neuropeptide Y; Pancreatic Polypeptide; Peptide Fragments; Peptide Hormones; Peptide YY; Pregnancy; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Teratogens; Vitamin A; Xanthenes | 2007 |
Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
Topics: Animals; Anti-Anxiety Agents; Arginine; Biomarkers; Corticotropin-Releasing Hormone; CREB-Binding Protein; Immunohistochemistry; Injections, Intraventricular; Male; Neurons; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Phosphorylation; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Third Ventricle | 2007 |
Selective role of neuropeptide Y receptor subtype Y2 in the control of gonadotropin secretion in the rat.
Topics: Animals; Arginine; Benzazepines; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Hypothalamus; Luteinizing Hormone; Male; Neuropeptide Y; Orchiectomy; Peptide Fragments; Peptide YY; Random Allocation; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Secretory Rate | 2007 |
Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
Topics: Adenylyl Cyclases; Animals; Arginine; Cell Line; Cell Membrane; Colforsin; Cricetinae; Cyclic AMP; Dimerization; Dose-Response Relationship, Drug; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; Humans; Luciferases, Renilla; Macaca mulatta; Mesocricetus; Microscopy, Confocal; Neuropeptide Y; Peptide Fragments; Radioligand Assay; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Transfection | 2007 |
Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats.
Topics: Acetylcysteine; Animals; Antioxidants; Arginine; Blood Pressure; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Hypertension; Male; Mesenteric Arteries; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Splanchnic Circulation; Superoxides; Sympathetic Nervous System | 2008 |
Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway.
Topics: Acetylcholine; Animals; Arginine; Benzazepines; Bradycardia; Carbachol; Choline O-Acetyltransferase; Cyclic AMP-Dependent Protein Kinases; Female; Guinea Pigs; Heart Rate; Immunohistochemistry; Isoquinolines; Neuropeptide Y; Protein Kinase C; Receptors, Neuropeptide Y; Signal Transduction; Sinoatrial Node; Sulfonamides; Vagus Nerve | 2008 |
NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning.
Topics: Animals; Arginine; Benzazepines; Dependovirus; Discrimination, Psychological; Excitatory Postsynaptic Potentials; Genetic Therapy; Genetic Vectors; Hippocampus; Injections; Long-Term Potentiation; Male; Memory Disorders; Neuronal Plasticity; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Recombinant Fusion Proteins; Transduction, Genetic; Transgenes | 2008 |
GPC receptors and not ligands decide the binding mode in neuropeptide Y multireceptor/multiligand system.
Topics: Amino Acid Sequence; Amino Acid Substitution; Animals; Arginine; Aspartic Acid; Binding Sites; Cells, Cultured; Chlorocebus aethiops; Conserved Sequence; COS Cells; Humans; Ligands; Models, Biological; Molecular Sequence Data; Neuropeptide Y; Receptors, Neuropeptide Y | 2008 |
Effects of NPY and the specific Y1 receptor agonist [D-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats.
Topics: Animals; Arginine; Brain; Drug Implants; Electric Stimulation; Electrodes, Implanted; Male; Neuropeptide Y; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reward; Self Stimulation; Substance Withdrawal Syndrome | 2008 |
The involvement of norepinephrine, neuropeptide Y, and nitric oxide in the cutaneous vasodilator response to local heating in humans.
Topics: Adrenergic alpha-Antagonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Adult; Arginine; Axons; Enzyme Inhibitors; Female; Hot Temperature; Humans; Male; Microdialysis; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Propranolol; Receptors, Neuropeptide Y; Receptors, Presynaptic; Reflex; Regional Blood Flow; Skin; Vasodilation; Yohimbine | 2008 |
Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum.
Topics: Animals; Animals, Newborn; Arginine; Benzazepines; Biophysical Phenomena; Chi-Square Distribution; Electric Stimulation; Excitatory Postsynaptic Potentials; Female; GABA Antagonists; Genetic Vectors; Glutamic Acid; Green Fluorescent Proteins; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Neurons; Neuropeptide Y; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Picrotoxin; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Tetrodotoxin; Transgenes | 2008 |
Endogenous PYY and NPY mediate tonic Y1- and Y2-mediated absorption in human and mouse colon.
Topics: Aged; Animals; Arginine; Benzazepines; Colon; Female; Humans; Intestinal Absorption; Male; Mice; Mice, Knockout; Neuropeptide Y; Peptide YY; Receptors, Neuropeptide Y | 2008 |
Y1 receptor knockout increases nociception and prevents the anti-allodynic actions of NPY.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Arginine; Behavior, Animal; Disease Models, Animal; Hot Temperature; Hyperalgesia; Inflammation; Male; Mice; Mice, Knockout; Neuropeptide Y; Pain; Pain Measurement; Receptors, Neuropeptide Y; Sciatic Neuropathy | 2008 |
Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Age Factors; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Blood Pressure; Captopril; Disease Models, Animal; Electric Stimulation; Hypertension; Imidazoles; Mesenteric Arteries; Neuropeptide Y; Prazosin; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 2; Receptors, Adrenergic, alpha-2; Receptors, Neuropeptide Y; Splanchnic Circulation; Sympathetic Nervous System | 2008 |
Modular synthesis of non-peptidic bivalent NPY Y1 receptor antagonists.
Topics: Anti-Anxiety Agents; Arginine; Calcium; Cells, Cultured; Humans; Inhibitory Concentration 50; Kinetics; Ligands; Neuropeptide Y; Receptors, Neuropeptide Y | 2008 |
The role of neuropeptide Y in the expression and extinction of fear-potentiated startle.
Topics: Amygdala; Animals; Anxiety Disorders; Arginine; Brain; Conditioning, Psychological; Cues; Extinction, Psychological; Fear; Injections, Intraventricular; Male; Neuropeptide Y; Neuropsychological Tests; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reflex, Startle | 2008 |
Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis.
Topics: Age of Onset; Alleles; Animals; Arginine; Atherosclerosis; Female; Genetic Predisposition to Disease; Genotype; Humans; Linkage Disequilibrium; Lod Score; Male; Mice; Mice, Transgenic; Middle Aged; Neuropeptide Y; Polymorphism, Genetic; Receptors, Neuropeptide Y | 2009 |
Neuropeptide Y fragments derived from neprilysin processing are neuroprotective in a transgenic model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Arginine; Benzazepines; Cells, Cultured; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Genetic Vectors; Humans; Mice; Mice, Transgenic; Neprilysin; Nerve Degeneration; Nerve Growth Factors; Neurons; Neuropeptide Y; Peptide Fragments; Receptors, Neuropeptide Y | 2009 |
Appetitive and consummatory ingestive behaviors stimulated by PVH and perifornical area NPY injections.
Topics: Animals; Appetitive Behavior; Arginine; Cricetinae; Dose-Response Relationship, Drug; Eating; Feeding Behavior; Fornix, Brain; Male; Microinjections; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Phodopus; Receptors, Neuropeptide Y; Time Factors | 2009 |
Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Arginine; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Imipramine; Injections, Intraperitoneal; Injections, Intraventricular; Male; Neuropeptide Y; Olfactory Bulb; Psychomotor Agitation; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y | 2009 |
Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.
Topics: Animals; Arginine; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Eating; Fluorescent Antibody Technique, Indirect; Immunohistochemistry; Injections, Intraventricular; Male; Microinjections; Neuropeptide Y; Nicotine; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Substance Withdrawal Syndrome; Time Factors | 2009 |
Neuropeptide Y and gamma-melanocyte stimulating hormone (gamma-MSH) share a common pressor mechanism of action.
Topics: Animals; Arginine; Cardiovascular Physiological Phenomena; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Energy Metabolism; gamma-MSH; Hormone Antagonists; Humans; Male; Mice; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Signal Transduction; Vasomotor System | 2009 |
Neuropeptide Y induces gonadotropin-releasing hormone gene expression directly and through conditioned medium from mHypoE-38 NPY neurons.
Topics: Activating Transcription Factor 1; Animals; Anti-Anxiety Agents; Arginine; Blotting, Western; Cell Line; Culture Media, Conditioned; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Gene Expression Regulation; Gonadotropin-Releasing Hormone; Neurons; Neuropeptide Y; Phosphorylation; Radioimmunoassay; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2009 |
Intracerebroventricular administration of 26RFa produces an analgesic effect in the rat formalin test.
Topics: Analgesics, Non-Narcotic; Animals; Anti-Anxiety Agents; Arginine; Formaldehyde; Hot Temperature; Injections, Intraventricular; Male; Narcotic Antagonists; Neuropeptide Y; Neuropeptides; Oligopeptides; Pain; Pain Measurement; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, G-Protein-Coupled; Spinal Cord | 2009 |
Involvement of neuropeptide Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates.
Topics: Analgesics, Opioid; Animals; Arginine; Behavior, Animal; Drug Tolerance; Hyperalgesia; Male; Morphine; Neuropeptide Y; Pain Measurement; Peripheral Nervous System Diseases; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sciatic Nerve; Substance Withdrawal Syndrome | 2009 |
Fear-reducing effects of intra-amygdala neuropeptide Y infusion in animal models of conditioned fear: an NPY Y1 receptor independent effect.
Topics: Amygdala; Analysis of Variance; Animals; Arginine; Conditioning, Classical; Dose-Response Relationship, Drug; Electroshock; Fear; Freezing Reaction, Cataleptic; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Models, Animal; Neuropeptide Y; Oligodeoxyribonucleotides, Antisense; Peptide Fragments; Receptors, Neuropeptide Y; Time Factors | 2009 |
Bivalent argininamide-type neuropeptide y y(1) antagonists do not support the hypothesis of receptor dimerisation.
Topics: Arginine; Cell Line; Humans; Ligands; Neuropeptide Y; Protein Multimerization; Receptors, Neuropeptide Y | 2009 |
Effect of pharmacological manipulations of neuropeptide Y and corticotropin-releasing factor neurotransmission on incubation of conditioned fear.
Topics: Acoustic Stimulation; Animals; Arginine; Benzazepines; Conditioning, Operant; Corticotropin-Releasing Hormone; Fear; Male; Neuropeptide Y; Pyridazines; Rats; Rats, Long-Evans; Receptors, Corticotropin-Releasing Hormone; Receptors, Neuropeptide Y; Synaptic Transmission; Thiazoles; Time Factors | 2009 |
Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious mice.
Topics: 5-Hydroxytryptophan; Acute Disease; Animals; Arginine; Benzazepines; Bethanechol; Colon; Consciousness; Diarrhea; Eating; Efferent Pathways; Gastric Emptying; Gastrointestinal Motility; Male; Mice; Mice, Inbred C57BL; Myenteric Plexus; Neuropeptide Y; Parasympathomimetics; Peptide Fragments; Peptide YY; Receptors, Neuropeptide Y; Restraint, Physical; Stress, Physiological | 2010 |
Neuropeptide Y Y1 receptors in the central nucleus of amygdala mediate the anxiolytic-like effect of allopregnanolone in mice: Behavioral and immunocytochemical evidences.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Arcuate Nucleus of Hypothalamus; Arginine; Central Nervous System Agents; Diazepam; Dose-Response Relationship, Drug; Electroshock; Immunohistochemistry; Male; Mice; Neuropeptide Y; Neuropsychological Tests; Nucleus Accumbens; Pregnanolone; Receptors, Neuropeptide Y; Septal Nuclei | 2010 |
NPY mediates ATP-induced neuroproliferation in adult mouse olfactory epithelium.
Topics: Adenosine Triphosphate; Aging; Animals; Arginine; Cell Proliferation; Dose-Response Relationship, Drug; Male; Mice; Models, Neurological; Neurogenesis; Neuropeptide Y; Olfactory Mucosa; Purinergic Antagonists; Pyridoxal Phosphate; Receptors, Neuropeptide Y; Receptors, Purinergic; Sensory Receptor Cells | 2010 |
Estrogen modulates the contribution of neuropeptide Y to baseline hindlimb blood flow control in female Sprague-Dawley rats.
Topics: Animals; Arginine; Blood Pressure; Estradiol; Female; Heart Rate; Hindlimb; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Muscle, Skeletal; Neuropeptide Y; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Regional Blood Flow | 2010 |
Neuropeptide Y directly inhibits neuronal activity in a subpopulation of gonadotropin-releasing hormone-1 neurons via Y1 receptors.
Topics: Adenylyl Cyclases; Animals; Arginine; Calcium; Embryo, Mammalian; Female; Gonadotropin-Releasing Hormone; Immunohistochemistry; In Vitro Techniques; Mice; Neurons; Neuropeptide Y; Polymerase Chain Reaction; Pregnancy; Receptors, Neuropeptide Y; Signal Transduction | 2010 |
Mutagenesis of human neuropeptide Y/peptide YY receptor Y2 reveals additional differences to Y1 in interactions with highly conserved ligand positions.
Topics: Arginine; Benzazepines; Binding Sites; Humans; Ligands; Mutagenesis, Site-Directed; Neuropeptide Y; Peptide YY; Receptors, Neuropeptide Y; Structure-Activity Relationship | 2010 |
Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy.
Topics: Animals; Apoptosis; Arginine; Benzazepines; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Activation; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Neuroblastoma; Neuropeptide Y; Receptors, Neuropeptide Y; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Xenograft Model Antitumor Assays | 2010 |
NPY promotes chemokinesis and neurogenesis in the rat subventricular zone.
Topics: Animals; Animals, Newborn; Arginine; Bromodeoxyuridine; Calcium; Cell Differentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Cerebral Ventricles; Enzyme Inhibitors; Nerve Tissue Proteins; Neural Stem Cells; Neurogenesis; Neurons; Neuropeptide Y; Peptide Fragments; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; RNA, Messenger | 2011 |
Attenuation of pain-related behavior evoked by injury through blockade of neuropeptide Y Y2 receptor.
Topics: Analysis of Variance; Animals; Arginine; Benzazepines; Disease Models, Animal; Dose-Response Relationship, Drug; Functional Laterality; Glial Fibrillary Acidic Protein; Hyperalgesia; Male; Motor Activity; Neuralgia; Neurons; Neuropeptide Y; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Rotarod Performance Test; Spinal Cord | 2011 |
Tonic inhibition of chronic pain by neuropeptide Y.
Topics: Animals; Arginine; Behavior, Animal; Benzazepines; Chronic Disease; Gene Expression Regulation; Mice; Mice, Knockout; Neuropeptide Y; Nociceptors; Pain; Posterior Horn Cells; Proto-Oncogene Proteins c-fos; Receptors, Neuropeptide Y; Synaptic Transmission | 2011 |
Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Agmatine; Animals; Arcuate Nucleus of Hypothalamus; Arginine; Clonidine; Drug Synergism; Eating; Feeding Behavior; Hyperphagia; Male; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Neuropeptide Y; Yohimbine | 2011 |
Refeeding after a 24-hour fasting deepens NREM sleep in a time-dependent manner.
Topics: Analysis of Variance; Angiotensin II; Animals; Anti-Anxiety Agents; Arginine; Blood Glucose; Body Temperature; Circadian Rhythm; Delta Rhythm; Drinking; Electroencephalography; Fasting; Fatty Acids; Feeding Behavior; Gene Expression Regulation; Male; Mice; Mice, Inbred ICR; Neuropeptide Y; Nitric Oxide Synthase Type I; RNA, Messenger; Sleep Stages; Triglycerides; Wakefulness | 2011 |
Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Arginine; Arousal; Behavior, Animal; Dose-Response Relationship, Drug; Electroshock; Environment; Feeding Behavior; Injections; Male; Neuropeptide Y; Rats; Rats, Long-Evans; Receptors, Neuropeptide Y; Septum of Brain | 2011 |
Influence of Neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Arginine; Biogenic Monoamines; Biosensing Techniques; Brain Chemistry; Catecholamines; Depression; Electrochemistry; Fluoxetine; Imipramine; Indoles; Male; Neuropeptide Y; Neuropeptides; Oxidation-Reduction; Peptide Fragments; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Selective Serotonin Reuptake Inhibitors | 2011 |
Neuropeptide Y impairs insulin-stimulated translocation of glucose transporter 4 in 3T3-L1 adipocytes through the Y1 receptor.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Arginine; Cell Membrane; Glucose; Glucose Transporter Type 4; Insulin; Mice; Neuropeptide Y; Phosphorylation; Protein Transport; Proto-Oncogene Proteins c-akt; Receptors, Neuropeptide Y; Up-Regulation | 2012 |
Role of neuropeptide Y Y₁ and Y₂ receptors on behavioral despair in a rat model of depression with co-morbid anxiety.
Topics: Amygdala; Analysis of Variance; Animals; Anxiety; Arginine; Autoradiography; Benzazepines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Delivery Systems; Exploratory Behavior; Hippocampus; Interpersonal Relations; Male; Neuropeptide Y; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Swimming; Time Factors | 2012 |
Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Animals, Newborn; Arginine; Autoradiography; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Enzyme Inhibitors; Female; Functional Laterality; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroblastoma; Neurodegenerative Diseases; Neuropeptide Y; Neuroprotective Agents; Nortropanes; Oligopeptides; Oxidopamine; Parkinson Disease; Protein Binding; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Substantia Nigra; Tyrosine 3-Monooxygenase | 2012 |
Fluoxetine, 17-β estradiol or folic acid combined with intra-lateral septal infusions of neuropeptide Y produced antidepressant-like actions in ovariectomized rats forced to swim.
Topics: Animals; Antidepressive Agents; Arginine; Behavior, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estradiol; Female; Fluoxetine; Folic Acid; Injections, Intraventricular; Locomotion; Neuropeptide Y; Ovariectomy; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Septal Nuclei; Swimming | 2011 |
The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder.
Topics: Animals; Arginine; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Humans; Male; Maze Learning; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Reflex, Startle; Resilience, Psychological; Stress Disorders, Post-Traumatic; Stress, Psychological | 2012 |
Distinct effects of NPY13-36, a specific NPY Y2 agonist, in a model of rodent endotoxemia on leukocyte subsets and cytokine levels.
Topics: Animals; Arginine; Benzazepines; Cells, Cultured; Cytokines; Endotoxemia; Leukocytes; Male; Neuropeptide Y; Peptide Fragments; Rats; Rats, Inbred Lew; Receptors, Neuropeptide Y | 2011 |
Central neuropeptide Y modulates binge-like ethanol drinking in C57BL/6J mice via Y1 and Y2 receptors.
Topics: Alcohol Drinking; Amygdala; Analysis of Variance; Animals; Arginine; Central Nervous System Depressants; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Gene Expression Regulation; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Neurons; Neuropeptide Y; Peptide Fragments; Receptors, Neuropeptide Y | 2012 |
Neuropeptide Y stimulates food intake in the Zebrafish, Danio rerio.
Topics: Animals; Arginine; Behavior, Animal; Brain; Eating; Feeding Behavior; Female; Hormone Antagonists; Hypothalamus; Infusions, Intraventricular; Male; Neuropeptide Y; Nutritional Status; Receptors, Neuropeptide Y; Zebrafish | 2012 |
Nicotine evoked improvement in learning and memory is mediated through NPY Y1 receptors in rat model of Alzheimer's disease.
Topics: Alzheimer Disease; Amygdala; Analysis of Variance; Animals; Arcuate Nucleus of Hypothalamus; Arginine; Colchicine; Dentate Gyrus; Disease Models, Animal; Escape Reaction; Learning; Male; Maze Learning; Memory; Neuropeptide Y; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Septal Nuclei | 2012 |
A role for neuropeptide Y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress.
Topics: Animals; Arginine; Benzazepines; Corticosterone; Eating; Female; Gastrointestinal Motility; Gastrointestinal Tract; Male; Mice; Mice, Knockout; Neuropeptide Y; Restraint, Physical; Sex Factors; Stress, Physiological | 2012 |
Y1R control of sciatic nerve blood flow in the Wistar Kyoto rat.
Topics: Animals; Arginine; Arteries; Ganglionic Blockers; Hexamethonium; Neuropeptide Y; Rats; Rats, Inbred WKY; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Regional Blood Flow; Sciatic Nerve; Signal Transduction; Ultrasonography, Doppler, Pulsed; Vasodilation | 2012 |
Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
Topics: Animals; Arginine; Cell Proliferation; Cells, Cultured; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Glomerular Mesangium; Glucagon-Like Peptide 1; Male; Models, Animal; Muscle, Smooth, Vascular; Neuropeptide Y; Peptide Fragments; Peptide YY; Proline; Pyrazines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sitagliptin Phosphate; Thymidine; Triazoles | 2012 |
Intracellular mechanisms coupled to NPY Y2 and Y5 receptor activation and lipid accumulation in murine adipocytes.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Arginine; Benzazepines; Cell Differentiation; Cell Proliferation; Coloring Agents; Lipid Metabolism; Mice; Neuropeptide Y; PPAR gamma; Protein Kinase Inhibitors; Receptors, Neuropeptide Y | 2012 |
Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.
Topics: Analysis of Variance; Animals; Arginine; Caspase 3; Corpus Striatum; Cyclic GMP; Drug Interactions; Male; Methamphetamine; Mice; Mice, Inbred ICR; Microinjections; Neuropeptide Y; Nitric Oxide Synthase Type II; Peptides; Protein Precursors; Receptors, Neuropeptide Y; RNA, Messenger; Tyrosine | 2012 |
Involvement of neuropeptide Y signaling in the antidepressant-like effect and hippocampal cell proliferation induced by kososan, a Kampo medicine, in the stress-induced depression-like model mice.
Topics: Animals; Antidepressive Agents; Arginine; Cell Proliferation; Depression; Disease Models, Animal; Drugs, Chinese Herbal; Hippocampus; Intracellular Signaling Peptides and Proteins; Male; Medicine, Kampo; Mice; Neuropeptide Y; Neuropeptides; Orexins; Signal Transduction; Stress, Psychological | 2012 |
Neuropeptide Y Y1 receptor knockdown can modify glutathione peroxidase and c-AMP response element-binding protein in phenylpropanolamine-treated rats.
Topics: Animals; Appetite Depressants; Appetite Regulation; Arginine; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Down-Regulation; Eating; Gene Knockdown Techniques; Glutathione Peroxidase; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Oligonucleotides, Antisense; Phenylpropanolamine; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Signal Transduction; Time Factors | 2013 |
Pre-diabetes augments neuropeptide Y1- and α1-receptor control of basal hindlimb vascular tone in young ZDF rats.
Topics: Acetylcholine; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Animals; Arginine; Blood Pressure; Drug Synergism; Heart Rate; Hindlimb; Male; Muscle, Skeletal; Neuropeptide Y; Nitric Oxide Donors; Nitroprusside; Prazosin; Prediabetic State; Rats; Receptors, Adrenergic, alpha-1; Receptors, Neuropeptide Y; Regional Blood Flow; Vasoconstriction | 2012 |
Differences in neuropeptide Y-induced secretion of endothelin-1 in left and right human endocardial endothelial cells.
Topics: Arginine; Endocardium; Endothelial Cells; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Immunohistochemistry; Microscopy, Confocal; Neuropeptide Y; Radioimmunoassay; Receptors, Neuropeptide Y | 2012 |
The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenografts.
Topics: Animals; Arginine; Breast Neoplasms; Calcium; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Mice; Mice, Nude; Neuropeptide Y; Receptors, Estrogen; Receptors, Neuropeptide Y; Tamoxifen | 2012 |
Lateral septal infusions of the neuropeptide Y Y2 receptor agonist, NPY(13-36) differentially affect different defensive behaviors in male, Long Evans rats.
Topics: Agonistic Behavior; Animals; Anxiety; Appetite; Arginine; Benzazepines; Dose-Response Relationship, Drug; Eating; Electroshock; Injections; Male; Neuropeptide Y; Peptide Fragments; Rats; Rats, Long-Evans; Receptors, Neuropeptide Y; Septum of Brain | 2013 |
[(3)H]UR-PLN196: a selective nonpeptide radioligand and insurmountable antagonist for the neuropeptide Y Y(2) receptor.
Topics: Arginine; Calcium Signaling; Dibenzazepines; Kinetics; Ligands; Neuropeptide Y; Protein Binding; Receptors, Neuropeptide Y; Structure-Activity Relationship; Tritium | 2013 |
Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
Topics: Amyloid beta-Peptides; Animals; Arginine; Benzazepines; Cerebral Cortex; Depression; Glutathione; Glutathione Peroxidase; Hippocampus; Injections, Intraventricular; Lipid Peroxidation; Male; Maze Learning; Memory Disorders; Mice; Motor Activity; Neuropeptide Y; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Receptors, Neuropeptide Y | 2013 |
Blockage of peripheral NPY Y1 and Y2 receptors modulates barorefex sensitivity of diabetic rats.
Topics: Animals; Arginine; Baroreflex; Benzazepines; Blood Pressure; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Experimental; Heart Rate; Hyperlipidemias; Male; Neuropeptide Y; Nitroprusside; Phenylephrine; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Triglycerides | 2013 |
Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats.
Topics: Action Potentials; Affective Symptoms; Analysis of Variance; Aniline Compounds; Animals; Arginine; Corticotropin-Releasing Hormone; Cyclohexanes; Disease Models, Animal; Excitatory Amino Acid Antagonists; Formaldehyde; GABA Antagonists; Hormone Antagonists; Hormones; In Vitro Techniques; Kynurenic Acid; Male; Membrane Potentials; Microdialysis; Neurons; Neuropeptide Y; Pain; Pain Measurement; Peptide Fragments; Pyridazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Septal Nuclei; Xanthenes | 2013 |
Feed intake and brain neuropeptide Y (NPY) and cholecystokinin (CCK) gene expression in juvenile cobia fed plant-based protein diets with different lysine to arginine ratios.
Topics: Amino Acid Sequence; Animals; Arginine; Brain; Cholecystokinin; Diet; Eating; Gene Expression; Lysine; Molecular Sequence Data; Neuropeptide Y; Perciformes; Plant Proteins, Dietary; Sequence Alignment | 2013 |
Neuropeptide Y induces secretion of high-mobility group box 1 protein in mouse macrophage via PKC/ERK dependent pathway.
Topics: Animals; Arginine; Butadienes; Cells, Cultured; Enzyme Inhibitors; HMGB1 Protein; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Neuroimmunomodulation; Neuropeptide Y; Nitriles; Protein Kinase C; Receptors, Neuropeptide Y; Staurosporine | 2013 |
Effect of neuropeptide Y on food intake in bullfrog larvae.
Topics: Animals; Anti-Anxiety Agents; Appetite Regulation; Arginine; Eating; Fasting; Feeding Behavior; Hypothalamus; Larva; Neuropeptide Y; Rana catesbeiana; Receptors, Neuropeptide Y; RNA, Messenger | 2013 |
Possible involvement of neuropeptide Y Y1 receptors in antidepressant like effect of agmatine in rats.
Topics: Agmatine; Animals; Antidepressive Agents; Arginine; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Injections, Intraventricular; Male; Motor Activity; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Swimming | 2013 |
Inhibition of peripheral NPY Y1 and Y2 receptors ameliorates the aberrant baroreceptor reflex sensitivity in streptozotocin induced diabetic rats.
Topics: Animals; Arginine; Baroreflex; Benzazepines; Blood Pressure; Bradycardia; Diabetes Mellitus, Experimental; Heart Rate; Myocardial Contraction; Neuropeptide Y; Rats; Receptors, Neuropeptide Y; Streptozocin | 2013 |
Noradrenaline and neuropeptide Y contribute to initial, but not sustained, vasodilatation in response to local skin warming in humans.
Topics: Adult; Arginine; Clonidine; Humans; Male; Neuropeptide Y; Nitric Oxide Synthase Type III; Nitroprusside; Norepinephrine; Propranolol; Skin; Skin Temperature; Vasodilation; Yohimbine | 2014 |
The neuropeptide Y Y1 receptor knockdown modulates activator protein 1-involved feeding behavior in amphetamine-treated rats.
Topics: alpha-Methyltyrosine; Amphetamine; Animals; Appetite; Arginine; Chromatin Immunoprecipitation; Feeding Behavior; Gene Knockdown Techniques; Hypothalamus; Injections, Intraventricular; Male; Neuropeptide Y; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; Receptor, Melanocortin, Type 4; Receptors, Neuropeptide Y; Transcription Factor AP-1 | 2013 |
Neuropeptide Y regulates the leptin receptors in rat hypothalamic and pituitary explant cultures.
Topics: Animals; Arginine; Female; Gene Expression; Gonadotropin-Releasing Hormone; Hypothalamus; Luteinizing Hormone; Neuropeptide Y; Ovulation; Pituitary Gland; Protein Isoforms; Rats; Rats, Sprague-Dawley; Receptors, Leptin; Receptors, Neuropeptide Y; Tissue Culture Techniques | 2014 |
Orexigenic response to tail pinch: role of brain NPY(1) and corticotropin releasing factor receptors.
Topics: Animals; Arginine; Body Weight; Brain; Corticotropin-Releasing Hormone; Eating; Ghrelin; Male; Neurons; Neuropeptide Y; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Somatostatin | 2014 |
Neuropeptide Y in the central nucleus of amygdala regulates the anxiolytic effect of agmatine in rats.
Topics: Agmatine; Animals; Anti-Anxiety Agents; Anxiety; Arginine; Cell Count; Central Amygdaloid Nucleus; Immunohistochemistry; Male; Motor Activity; Neuropeptide Y; Neuropsychological Tests; Nucleus Accumbens; Photomicrography; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Septal Nuclei | 2014 |
Involvement of amygdaloid neuropeptide Y in the anxiolytic effects of acupuncture during ethanol withdrawal in rats.
Topics: Acupuncture Therapy; Amygdala; Animals; Anxiety; Arginine; Benzazepines; Cyclic AMP Response Element-Binding Protein; Ethanol; Male; Maze Learning; Neuropeptide Y; Phosphorylation; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Substance Withdrawal Syndrome | 2014 |
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension.
Topics: Adult; Animals; Arginine; Cell Proliferation; Epinephrine; Female; Humans; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Indoles; Lung; Male; Mice, Inbred C57BL; Monocrotaline; Myocytes, Smooth Muscle; Neuropeptide Y; Pulmonary Artery; Pyrroles; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2014 |
Neuropeptide Y attenuates anxiety- and depression-like effects of cholecystokinin-4 in mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Arginine; Brain; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Immunohistochemistry; Male; Mice; Motor Activity; Neuropeptide Y; Neuropsychological Tests; Psychotropic Drugs; Receptors, Neuropeptide Y; Social Behavior; Swimming; Tetragastrin | 2014 |
Diurnal fluctuations in HPA and neuropeptide Y-ergic systems underlie differences in vulnerability to traumatic stress responses at different zeitgeber times.
Topics: Administration, Intranasal; Amygdala; Animals; Arcuate Nucleus of Hypothalamus; Arginine; Circadian Rhythm; Corticosterone; Hippocampus; Hypothalamo-Hypophyseal System; Male; Maze Learning; Microinjections; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Psychological Trauma; Rats; Receptors, Neuropeptide Y; Reflex, Startle; Stress, Psychological; Time Factors | 2015 |
Neuropeptide Y is crucial for nutritional state-dependent regulation of maternal behavior.
Topics: Animals; Arginine; Dorsal Raphe Nucleus; Energy Intake; Fasting; Female; GABAergic Neurons; Maternal Behavior; Mice; Neuropeptide Y; Receptors, Neuropeptide Y; Serotonergic Neurons | 2015 |
N(ω)-Carbamoylation of the Argininamide Moiety: An Avenue to Insurmountable NPY Y1 Receptor Antagonists and a Radiolabeled Selective High-Affinity Molecular Tool ([(3)H]UR-MK299) with Extended Residence Time.
Topics: Amides; Animals; Arginine; Binding, Competitive; Cell Line; CHO Cells; Cricetinae; Cricetulus; Diphenylacetic Acids; Fluorescent Dyes; Fura-2; Half-Life; Humans; Isotope Labeling; Molecular Probes; Neuropeptide Y; Radiopharmaceuticals; Receptors, Neuropeptide; Receptors, Neuropeptide Y; Structure-Activity Relationship | 2015 |
Neuropeptide Y Impairs Retrieval of Extinguished Fear and Modulates Excitability of Neurons in the Infralimbic Prefrontal Cortex.
Topics: Animals; Arginine; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Corticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Extinction, Psychological; Fear; Glutamate Decarboxylase; Learning Disabilities; Male; Mental Recall; Neurons; Neuropeptide Y; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Synaptic Potentials | 2016 |
Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.
Topics: Angiotensin II; Arginine; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Ligands; Molecular Structure; Neuropeptide Y; Neurotensin; Oligopeptides; Peptide Fragments; Receptors, Angiotensin; Receptors, Neuropeptide; Receptors, Neurotensin; Structure-Activity Relationship | 2016 |
Ghrelin activates hypophysiotropic corticotropin-releasing factor neurons independently of the arcuate nucleus.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Corticosterone; Corticotropin-Releasing Hormone; GABA Antagonists; gamma-Aminobutyric Acid; Gene Knockdown Techniques; Ghrelin; Infusions, Intraventricular; Male; Mice; Muscimol; Neurons; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Receptors, Ghrelin | 2016 |
Insulin increases sympathetic nerve activity in part by suppression of tonic inhibitory neuropeptide Y inputs into the paraventricular nucleus in female rats.
Topics: Animals; Arginine; Baroreflex; Blood Pressure; Female; Heart Rate; Hypoglycemic Agents; Insulin; Melanocyte-Stimulating Hormones; Microinjections; Neuropeptide Y; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Receptors, Neuropeptide Y; Sympathetic Nervous System | 2016 |
Evidence for the involvement of neuropeptide Y in the antidepressant effect of imipramine in type 2 diabetes.
Topics: Animals; Antidepressive Agents, Tricyclic; Arginine; Blood Glucose; Central Amygdaloid Nucleus; Depression; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Imipramine; Male; Mice; Motor Activity; Neuropeptide Y; Nucleus Accumbens; Receptors, Neuropeptide Y; Septal Nuclei; Streptozocin | 2016 |
NPY
Topics: Animals; Animals, Outbred Strains; Arginine; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Atria; Heart Ventricles; Isometric Contraction; Myocardial Contraction; Myocardium; Neuropeptide Y; Rats; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Tissue Culture Techniques | 2017 |
Neuropeptide Y prolongs non-social memory and differentially affects acquisition, consolidation, and retrieval of non-social and social memory in male mice.
Topics: Animals; Arginine; Benzazepines; Brain; Discrimination, Psychological; Infusions, Intraventricular; Male; Memory; Mice; Neuropeptide Y; Receptors, Neuropeptide Y; Social Behavior | 2017 |
Leptin siRNA promotes ovarian granulosa cell apoptosis and affects steroidogenesis by increasing NPY2 receptor expression.
Topics: Androstenedione; Animals; Apoptosis; Arginine; Benzazepines; Cell Proliferation; Dinoprostone; Female; Follicle Stimulating Hormone; Gene Knockdown Techniques; Gonadal Steroid Hormones; Granulosa Cells; Humans; Janus Kinase 2; Leptin; Mice; Mice, Inbred C57BL; Neuropeptide Y; Progesterone; Receptors, Neuropeptide Y; RNA, Small Interfering; STAT3 Transcription Factor | 2017 |
Kisspeptin Stimulates Growth Hormone Release by Utilizing Neuropeptide Y Pathways and Is Dependent on the Presence of Ghrelin in the Ewe.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Atropine; Fasting; Female; Fluorescent Antibody Technique; Ghrelin; Growth Hormone; Growth Hormone-Releasing Hormone; Kisspeptins; Muscarinic Antagonists; Neuropeptide Y; Oligopeptides; Proto-Oncogene Proteins c-fos; Receptors, Ghrelin; Receptors, Neuropeptide Y; Sheep; Sheep, Domestic; Somatostatin-Secreting Cells | 2017 |
Central Neuropeptide Y Plays an Important Role in Mediating the Adaptation Mechanism Against Chronic Stress in Male Rats.
Topics: Adaptation, Physiological; Animals; Arginine; Corticosterone; Corticotropin-Releasing Hormone; Gastrointestinal Motility; Male; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Stress, Physiological | 2018 |
Structural basis of ligand binding modes at the neuropeptide Y Y
Topics: Arginine; Binding Sites; Crystallography, X-Ray; Dihydropyridines; Diphenylacetic Acids; Humans; Inositol Phosphates; Ligands; Molecular Docking Simulation; Mutant Proteins; Mutation; Neuropeptide Y; Nuclear Magnetic Resonance, Biomolecular; Phenylurea Compounds; Protein Binding; Receptors, Neuropeptide Y; Structure-Activity Relationship; Substrate Specificity | 2018 |
Neuropeptide Y is Up-regulated and Induces Antinociception in Cancer-induced Bone Pain.
Topics: Animals; Arginine; Behavior, Animal; Benzazepines; Cancer Pain; Female; Male; Musculoskeletal Pain; Neuropeptide Y; Nociception; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Spinal Cord Dorsal Horn | 2018 |
Melatonin Induces Osteoblastic Differentiation of Mesenchymal Stem Cells and Promotes Fracture Healing in a Rat Model of Femoral Fracture via Neuropeptide Y/Neuropeptide Y Receptor Y1 Signaling.
Topics: Alkaline Phosphatase; Animals; Arginine; Cell Differentiation; Collagen Type I; Collagen Type I, alpha 1 Chain; Core Binding Factor Alpha 1 Subunit; Femoral Fractures; Fracture Healing; Male; Melatonin; Mesenchymal Stem Cells; Neuropeptide Y; Osteoblasts; Osteocalcin; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Signal Transduction | 2018 |
Neuropeptide Y impairs the acquisition of conditioned defeat in Syrian hamsters.
Topics: Animals; Arginine; Behavior, Animal; Conditioning, Psychological; Cricetinae; Dominance-Subordination; Infusions, Intraventricular; Male; Neuropeptide Y | 2019 |
Sex differences in the sympathoexcitatory response to insulin in obese rats: role of neuropeptide Y.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Arginine; Baroreflex; Female; Insulin; Male; Neural Inhibition; Neuropeptide Y; Obesity; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Sex Factors; Sympathetic Nervous System | 2019 |
Expression of neuropeptide Y is increased in an activated human HSC cell line.
Topics: Adaptor Proteins, Signal Transducing; Arginine; Cell Cycle Proteins; Cell Line, Transformed; Fibrosis; Hepatic Stellate Cells; Humans; Neuropeptide Y; Phosphorylation; Receptors, Neuropeptide Y; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases | 2019 |
Neuroendocrine modulation of predator avoidance/prey capture tradeoffs: Role of tectal NPY2R receptors.
Topics: Animals; Arginine; Benzazepines; Feeding Behavior; Female; Neuropeptide Y; Neurosecretory Systems; Predatory Behavior; Receptors, Neuropeptide Y; Superior Colliculi; Swine; Xenopus laevis | 2019 |
Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors.
Topics: Animals; Arginine; Benzazepines; Cues; Extinction, Psychological; Fear; Memory; Mice; Neuropeptide Y; Receptors, Neuropeptide Y; Time Factors | 2019 |
Neuropeptide Y release in the rat spinal cord measured with Y1 receptor internalization is increased after nerve injury.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Arginine; Calcium Channel Blockers; Capsaicin; Cyclic AMP-Dependent Protein Kinases; Excitatory Amino Acid Antagonists; Hyperalgesia; Indoles; Interneurons; Lidocaine; Male; Microscopy, Confocal; Neuropeptide Y; Nociception; omega-Conotoxins; Peripheral Nerve Injuries; Posterior Horn Cells; Potassium Chloride; Protein Transport; Protein Tyrosine Phosphatases; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide Y; Sensory System Agents; Spinal Cord; Spinal Nerve Roots; TRPV Cation Channels; Voltage-Gated Sodium Channel Blockers | 2019 |
Neuropeptide Y increases differentiation of human olfactory receptor neurons through the Y1 receptor.
Topics: Arginine; Cell Differentiation; Cells, Cultured; Humans; Neuropeptide Y; Olfactory Mucosa; Olfactory Receptor Neurons; Receptors, Neuropeptide Y; Signal Transduction | 2019 |
Cardiac sympathetic activation circumvents high-dose beta blocker therapy in part through release of neuropeptide Y.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arginine; Disease Models, Animal; Neuropeptide Y; Receptors, Neuropeptide Y; Sus scrofa; Sympathetic Nervous System; Tachycardia, Ventricular | 2020 |
A role for NPY-NPY2R signaling in albuminuric kidney disease.
Topics: Albuminuria; Animals; Arginine; Benzazepines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Down-Regulation; Doxorubicin; Humans; Insulin; Kidney Diseases; Kidney Glomerulus; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neuropeptide Y; Podocytes; Proteomics; Receptors, Neuropeptide Y; Signal Transduction | 2020 |
Neuropeptide Y and glutamatergic mechanisms in the amygdala and ventral hippocampus differentially mediate impaired social behavior in diabetic mice.
Topics: Animals; Arginine; Basolateral Nuclear Complex; Behavior, Animal; Benzazepines; Cognitive Dysfunction; Diabetes Complications; Diabetes Mellitus, Experimental; Excitatory Amino Acid Antagonists; Hippocampus; Male; Mice; Mice, Inbred ICR; Neuropeptide Y; Receptors, AMPA; Receptors, Neuropeptide Y; Social Behavior | 2021 |
Neuropeptide Y Reduces Social Fear in Male Mice: Involvement of Y1 and Y2 Receptors in the Dorsolateral Septum and Central Amygdala.
Topics: Amygdala; Animals; Arginine; Benzazepines; Fear; Male; Mice; Neuropeptide Y; Phobia, Social; Receptors, Neuropeptide Y; Septum of Brain | 2021 |
N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y
Topics: Amino Acid Sequence; Arginine; Cyclization; HEK293 Cells; Humans; Ligands; Molecular Docking Simulation; Neuropeptide Y; Protein Binding; Receptors, Neuropeptide Y | 2021 |
Restraint stress potentiates neuropeptide Y-mediated impairment on spatial memory in rats.
Topics: Animals; Arginine; Behavior, Animal; Benzazepines; Disease Models, Animal; Male; Memory Disorders; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Restraint, Physical; Spatial Memory; Stress, Psychological | 2022 |
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes.
Topics: Animals; Arginine; Diabetes Mellitus, Type 2; Glucose; Glycemic Control; Insulin; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Neuropeptide Y; Obesity; Receptors, Neuropeptide Y | 2022 |